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The medical devices industry has a healthy growing trend nowadays and a promised 
future. However, a broad range of materials for selection and several specific require-
ments which concern both the functionality and safety of products are regarded as diffi-
culties by manufacturers who want to set foot in this area. The goal of this thesis is to 
illustrate a clear pathway from raw material to final products for the manufacturers with 
production experience of polymeric material based devices. 
This thesis is divided into two parts. The first half of this study is a synopsis of a 
valid production of medical devices. At each processing stage, the requirements and 
corresponded solutions are generally discussed based on scientific publication, industri-
al experience and/or related standards and regulation. To emphasis on product valida-
tion, the discussion of regulatory issues is infiltrated along the whole medical devices 
processing procedure. The becoming manufacture can follow this synopsis to evaluate 
the relevant requirements and solutions. 
The Second half of this thesis is focusing on polymeric materials in a material-
application manner. As a well-established material category which used in medical de-
vices industry, polymeric materials are preferred candidates due to their processing flex-
ibility, low cost and function diversity. Silicone rubber, thermoplastics and thermo-
plastic elastomers are three grouped objects with thorough discussion. Subsequently, the 
possible applications are introduced and categorised by contacting condition with hu-
man body. In this part, the commercialized materials and available applications are 
summarized to provide a direct impression of selection for manufacturers. As the end of 
comprehensive discussion, two case studies are given to illustrate the practice in reality. 
In this part, the manufacturer can choose the interested material and move forward to 
possible application as a fast start-up. 
  
ii 
 
PREFACE 
 
 
This thesis is sponsored by Teknikum Yhtiöt Oy. Great thanks to my supervisors: Mirva 
Mustakangas (R&D Director, Teknikum Yhtiöt Oy) and Professor Minna Kellomäki 
(Tampere University of Technology), I cannot achieve this study without their kind help 
and advice. Not only have the knowledge been acquired, but also the attitude of dealing 
with problems is precious experience I have learnt. I also would like to thank my family 
which is the power to push me moving forward. 
 
10 April 2014 
Hang Yu 
iii 
 
 ABBREVIATIONS 
 
General terms: 
FDA Food and Drug Administration 
ISO International Standardization Organization 
MHLW Ministry of Health, Labour and Welfare 
SAL Sterility Assurance Level 
API Active Pharmaceutical Ingredients 
DUR Dose Uniformity Ratio 
EtO Ethylene Oxide 
DOE Design of Experiment 
MRI Magnetic Resonance Imaging 
 
Silicone rubber: 
LSR Liquid Silicon Rubber 
PDMS Polydimethylsiloxane 
PDES Polydiethylsiloxane 
PDPS Polydiphenylsiloxane 
RTV Room Temperature Vulcanized 
HTV High Temperature Vulcanized 
FSR Flourosilicone Rubber 
HCR High Consistency Rubber 
 
Thermoplastics: 
PVC-U Rigid Polyvinyl Chloride  
PVC-P Plasticized Polyvinyl Chloride 
UHMWPE Ultrahigh Molecular Weight Polyethylene 
PP Polypropylene 
COC Cyclic Olefin Copolymers 
PS Polystyrene 
PMMA Polymethyl Methacrylate 
PC Polycarbonate 
PU Polyurethane 
PET Polyethylene Terephthalate 
PBT Polybutylene Terephthalate 
PCT Polycyclohexylenedimethylene Terephthalate 
PETG Polyethylene Terephthalate Glycol 
PCTG Polycyclohexylenedimethylene Terephthalate Glycol 
PCTA Polycyclohexylenedimethylene Terephthalate Acid 
PA Polyamide 
PSU Polysulfone 
PES Polyether Sulfone 
iv 
 
PPSU Polyphenylene Sulfone 
PEI Polyether-Imide 
PAI Polyamide-Imide 
PPS Polyphenylene Sulfide 
PEEK Polyether Ether Ketone 
LCP Liquid Crystalline Polymer  
PTFE Polytetrafluoroethylene 
PFA Perfluoro Alkoxy Copolymer 
FEP Fluorinated Ethylene Propylene Copolymer 
PVDF Polyvinylidene fluoride 
PCTFE Polychlorotrifluoroethylene 
ETFE Ethylene Tetrafluoroethylene Copolymer 
ECTFE Ethylene Chlorotrifluoroethylene Copolymer 
ABS Acrylonitrile Butadiene Styrene 
SAN Styrene Acrylonitrile 
ASA Acrylate Styrene Acrylonitrile 
MABS Methacrylate Acrylonitrile Butadiene Styrene 
SBC Styrene Butadiene Copolymer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
TABLE OF CONTENTS  
 
Abstract .............................................................................................................................. i 
Preface............................................................................................................................... ii 
Abbreviations ................................................................................................................... iii 
1. Introduction ............................................................................................................... 1 
2. Processing procedure synopsis ................................................................................. 3 
2.1 Initial infrastructure: Clean room and sterilization facility ............................... 4 
2.1.1 Clean room ............................................................................................ 4 
2.1.2 Sterilization ........................................................................................... 6 
2.2 Feasible analysis for production...................................................................... 14 
2.2.1 Material and processing method selection .......................................... 14 
2.2.2 Design of experiments......................................................................... 15 
2.3 Packaging and labelling .................................................................................. 20 
2.4 Regulatory issues ............................................................................................ 23 
3. Classification of medical devices............................................................................ 26 
3.1 Biomaterials .................................................................................................... 26 
3.1.1 Ceramic and glass ............................................................................... 26 
3.1.2 Metallic material ................................................................................. 27 
3.1.3 Polymeric material .............................................................................. 27 
3.1.4 Composite material ............................................................................. 27 
3.2 Disposable versus reusable ............................................................................. 28 
3.3 Classification by applications ......................................................................... 28 
4. Polymeric materials in medical field ...................................................................... 30 
4.1 Silicone rubber ................................................................................................ 30 
4.1.1 Properties of liquid silicone rubber ..................................................... 31 
4.1.2 Processing of liquid silicone rubber .................................................... 34 
4.2 Thermoplastics ................................................................................................ 36 
4.2.1 Property of thermoplastics .................................................................. 37 
4.2.2 Processing of thermoplastics ............................................................... 42 
4.3 Thermoplastic elastomers................................................................................ 42 
4.3.1 Properties of thermoplastic elastomers ............................................... 43 
4.3.2 Processing of thermoplastic elastomers .............................................. 44 
5. Medical applications ............................................................................................... 45 
5.1 Extracorporeal storage application .................................................................. 47 
5.1.1 Liquid or gas channeling devices ........................................................ 47 
5.1.2 Liquid or gas storing devices .............................................................. 49 
5.1.3 Liquid or gas administrating devices .................................................. 50 
5.2 Extracorporeal non-storage application .......................................................... 52 
5.2.1 Surgical instrument ............................................................................. 52 
5.2.2 Protective devices................................................................................ 52 
5.2.3 Medical instrumentation component ................................................... 54 
vi 
 
5.3 Overmolding ................................................................................................... 55 
5.4 Case study ....................................................................................................... 57 
6. Conclusion .............................................................................................................. 63 
Bibliography ................................................................................................................... 64 
Appendix 1 ...................................................................................................................... 75 
Appendix 1.1 ........................................................................................................... 75 
Appendix 1.2 ........................................................................................................... 76 
Appendix 2 ...................................................................................................................... 77 
Appendix 2.1 ........................................................................................................... 77 
Appendix 2.2 ........................................................................................................... 79 
 
1 
 
1. INTRODUCTION 
Despite worldwide economic slowdown or even recession, the global medical devices 
industry has continued growing healthily in the past decade. Although developed mar-
kets dominate medical devices sales today (US, EU, Japan accounts for over 75% of 
total sales), the emerging markets such as China, India, and Latin America are seeing 10 
to 15% annual growth rates in the medical devices market, expectedly.
[1][2]
 The driving 
forces in these emerging markets are the breakage of historical barrier which, mean-
while, improving of affordability, accessibility and acceptability. 
According to FDA and European Commission’s definitions, the term ‘medical de-
vice’ covers a broad range of engineering apparatus, instruments, machine, contrivance, 
implant, in vitro reagent, or other similar or related article, including a component part, 
or accessory.
[46][117]
 Generally, syringes, medical tubing, blood bags, sutures, these 
common tools in hospital; ECG machine, CT, MRI, these diagnosis devices; and artifi-
cial heart, joint prosthesis, all can be called medical devices. This variety gives manu-
facturer the opportunity to step into this industry by their familiar approach. For exam-
ple, a metal forging company can fabricate some metallic parts of medical devices when 
the specific requirements have been met. 
However, some production requirements of medical devices often show their brutal-
ity to the newly recruited companies that would hold them back in exploring this area. 
Therefore, it is necessary to consult and examine the requirements and capacity of the 
company thoroughly before and during development of new products. A systematic 
analysis of the pathway from raw material selection to final products can ease the so-
phisticated consideration procedure of manufacturer, and it is the goal of this thesis 
study. 
Starting with introduction of processing requirements in production plant such as 
clean room and sterilization, a general procedure of exploiting new medical devices 
production is discussed. The regulatory issues are often regarded as obstacles to deal 
with; however, the valid production cannot be achieved without regulatory approval. 
Therefore, the discussion of regulatory issues should be infiltrated along the whole med-
ical devices processing procedure. 
 Being a manufacturer of medical devices, which probably as a role of contracted 
supplier, the material selection would be a challenge. Firstly, the intended use of the 
device should be clear. Secondly, the material selection would determine the processing 
condition, and vice versa. Moreover, the material selection can have great influence on 
the properties of final products. Among numerous material options, plastics and elasto-
mers show their advantage on the nature of low cost, design flexibility, good process-
 2 
ability, broad range of physical and mechanical property, biocompatibility, sterilization 
resistance, etc.
[1][43]
 Nevertheless, this diversity of plastics and elastomers gives the 
manufacturer difficulty to make decision.  
In this study, plastics and elastomers are grouped into three categories: liquid sili-
cone rubber, thermoplastic, and thermoplastic elastomer; while each category has its 
pros and cons. The silicone rubber has been introduced with many excellent properties 
including chemical and extreme thermal stability, low surface tension, hydrophobicity 
and gas permeability with expanded medical application since 1960s and today are one 
of the most thoroughly tested and important biomaterials.
[3] 
Thermoplastics comprise 
several synthetic polymer groups: commodity, engineering, and high performance ther-
moplastic. In this category, processing experience of the certain kind material is a key 
factor for selection by manufacturer. Thermoplastic elastomers are a series of synthetic 
polymers that combine the properties of vulcanized rubber with the processing ad-
vantages of conventional thermoplastics.
[87]
 In other words, they allow the production of 
rubber-like articles using the fast processing equipment developed by the thermoplastics 
industry.  
The medical applications of such materials keep improving and diversifying as long 
as the progressing in material science and technology. The demands from basic function 
to ergonomic and aesthetic achievement have inspired the designer and manufacturer to 
presume more efficient, qualified, and exquisite products. For this purpose, the variety 
of formulation and compounds of polymers are booming all the time. However, for the 
sake of safety, some products should be made from maturely commercialized material 
which is recognized by authorities such as FDA or ISO. 
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2. PROCESSING PROCEDURE SYNOPSIS 
On the precondition of existing design concept, a pathway from raw material to final 
product should be established for manufacturer to achieve a successful production of 
medical devices. This final product can be either an integrated functionalized system or 
a component/part of it. Apart from the sophisticated initial concept design phase, a 
manufacturer or contracted supplier plays an important role to take the design drawing 
into real product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: A flow chart of processing procedure of medical devices from raw material to 
final product 
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As shown in Figure 1, several steps are involved to achieve a valid production of 
medical devices. At the beginning, a design paper is done by its inventor. At this stage, 
the function, dimensional parameters, physical and mechanical properties, and chemical 
property according to the function should be well defined. The inventor may appoint 
material and processing method, sometimes, but it is not necessary. Meanwhile, the 
clean room and sterilization facility is a sign of qualified manufacturer which can draw 
the interests of inventor (customer) to corporate. However, they are not always a must 
for some devices design; high precision and consistency is the priority, instead. 
With an existing design, a manufacturer starts to analyse the feasible production 
plan under the regulations from ISO or FDA which equivalent to the designate require-
ments. In this study, the main applied instructive paper is adopted within European Un-
ion Commission in order to get CE mark as a certain purpose. 
2.1 Initial infrastructure: Clean room and sterilization facility 
In order to achieve the required cleanliness of final product, the contamination is con-
trolled before, during and after production. The clean room can ensure the airborne par-
ticles remain in a minimized concentration and restrain the generation of these particles 
which caused by air flow and operation under controlled environment.
[4]
  
The sterilization is either a physical or chemical approach that eliminates all forms 
of life, especially microorganisms.
[5]
 Sterilization can be done after packaging or before 
use which mainly depends on sterilization method and the purpose of device.  
It raises the question that when clean room, and/or sterilization is needed. The clean 
room provides a well-controlled processing environment that allows the manufacture to 
keep the risk of both inorganic and organic contamination in a low level consistently. 
However, clean room just can minimize the concentration of contamination; while steri-
lization eliminates the microorganism existing due to multiplication nature of bacteria: 
even if one of a billion organisms survives, there is a possibility to rapid multiplication 
and contamination of the substrate.
[5]
 In other words, sterilization implies an absolute 
inactivation of organisms. Therefore, the manufacture should make a choice of clean 
room, and/or sterilization according to the requirements to be fulfilled. 
2.1.1 Clean room 
In high technological industries, such as electronics, optical and biological industries, 
the production quality is affected by the airborne particles or dust. Air filter being used 
in common heating ventilation air conditioning (HVAC) system can never collect these 
particles, meanwhile, the temperature, pressure, humidity and others factors that make 
the room suitable for fabrication should be in a controlled manner as well. A matched 
cleanliness cannot be found in the natural world; therefore, a man-made controlled-
environment: clean room, is introduced for such purpose.
[6]
 The demand of clean room 
for medical devices processing is depended on relevant regulations and requests of a 
customer. For instance, when the product cannot match the cleanliness level after thor-
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oughly washing and sterilization as a result of contamination, a clean room is an option 
to shoot this trouble. In addition, the clean room keeps the production validation in a 
consistent trend.
[4]
 
A clean room is defined in the International Organization For standardization (ISO) 
standard 14644-1 Cleanrooms and associated controlled environments -- Part 1: Clas-
sification of air cleanliness as: 
“room in which the concentration of airborne particles is controlled, and which is 
constructed and used in a manner to minimize the introduction, generation, and reten-
tion of particles inside the room and in which other relevant parameters, e.g. tempera-
ture, humidity, and pressure are controlled as necessary”.[4] 
ISO 14644-1 is adopted by the industries except pharmaceutical manufacturers in 
both the US and EU. Cleanrooms used for pharmaceutical manufacturing have their 
own standards.
[7]
 
According to this definition, to achieve the minimization of introduction, generation, 
and retention of particle, an exceptionally large quantity of filtered air is supplied into 
this room firstly. This air is used to dilute and remove the particle, bacteria and chemi-
cals dispersed from personnel, machinery and other sources within the room; and to 
pressurize the room and ensure that no dirty air flows into the cleanroom.
[4]
 Meanwhile, 
the building material of clean room should inhibit the particle generation fundamentally 
and can be easily cleaned. In addition, personnel are enveloped by specific clothing in 
clean room to minimize their dispersion of particle and microorganisms.
[10]
 
The building of clean room should be done under consulting experts who are famil-
iar with the practical issue relates to standards. The air cleanliness level by particle con-
centration is the indicator of the level of a clean room, as shown in Table 1.  
According to this classification, for example, an ISO Class 5 clean room contains no 
more than 832 counted particles with diameter range from 1 to 5 micrometre per cubic 
meter, no more than 3520 counted particles with diameter range from 0.5 to 5 microme-
tre per cubic meter, no more than 10200 counted particles with diameter range from 0.3 
to 5 micrometre per cubic meter, the rest can be done in the same manner. 
It is notable that the first edition of this classification was published in 1999; the 
newest edition is still in the stage 40.93: Full report circulated: decision for new DIS 
(draft international standards) ballot. Some modifications have been made in the new 
edition which is more consistent and scientific, as well as easier to use.
[8]
 Whether using 
the old version or newest DIS version is based on the consulted verification and confi-
dence level. 
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Table 1: Air cleanliness classification table by particle concentration
[8]
 
(Reproduced from the new ISO/DIS 14644-1 with permission of ISO) 
Once the clean room is in use, the particle concentration must be monitored routine-
ly or continuously at critical locations during operation and a periodic re-classification 
should be applied.
[8]
 A particle count is done each and every time a user of the clean 
room facility is ready to exit the facility. In such a manner, the particle contamination is 
correlated to amount of use, type of work done and by source of potential contamination. 
The maintenance of clean room includes: 1) trash removal; 2) replacement of tacky 
mats; 3) occasional cleaning of all surface of cleanroom. However, the clean room 
should be completely re-cleaned when the upper limit of acceptable contamination is 
approaching.
[9]
 The cost of maintenance is composed by material/system consuming and 
the personnel such as clean room manager.
[10] 
2.1.2 Sterilization 
To eliminate all microorganisms which may arouse interaction by contacting with med-
ical devices, an effective sterilization is applied to the products at certain stage before 
use if necessary and applicable. The timing of sterilization can be after packaging by 
manufacturer or before use/reuse in hospital (more generally, the place where the device 
is intended to functionalize). Efficient sterilization can be achieved by physical or 
chemical way depends on material type and facility. The common physical approach 
comprises autoclave (and dry heat), gamma and e-beam irradiation; the chemical way is 
ethylene oxide (EtO) gas.
[13]
 Due to various molecular composition and sensitivity of 
ISO 
classification 
number (N) 
Maximum allowable concentrations (particles/m
3
) for particles equal to and greater 
than the considered sizes shown below 
a
 
0,1 μm 0,2 μm 0,3 μm 0,5 μm 1 μm 5 μm 
ISO Class 1 10 
b
 d d d d e 
ISO Class 2 100 24 
b
 10 
b
 d d e 
ISO Class 3 1 000 237 102 35 
b
 d e 
ISO Class 4 10 000 2 370 1 020 352 83 
b
 e 
ISO Class 5 100 000 23 700 10 200 3 520 832 e 
ISO Class 6 1 000 000 237 000 102 000 35 200 8 320 293 
ISO Class 7 c c c 352 000 83 200 2 930 
ISO Class 8 c c c 3 520 000 832 000 29 300 
ISO Class 9 c c c 35 200 000 8 320 000 293 000 
a
 All concentrations in the Table are cumulative, e.g. for ISO Class 5, the 10 200 particles shown at 0,3 μm 
include all particles equal to and greater than this size. 
b
 These concentrations will lead to large air sample volumes for classification. Sequential sampling pro-
cedure may be applied; see Annex D. 
c
 Concentration limits are not applicable in this region of the Table due to very high particle concentra-
tion. 
d
 Sampling and statistical limitations for particles in low concentrations make classification inappropriate. 
e
 Sample collection limitations for both particles in low concentrations and sizes greater than 1 μm make 
classification inappropriate, due to potential particle losses in the sampling system. 
 7 
plastic and elastomer, the properties of material are undergoing an irreversible change 
by exposing to some sterilization conditions. As a result, it is necessary to take material 
selection into consideration when choosing sterilization method, and vice versa.  
The basic requirement for sterilization is to gain effective result without damaging 
the device. Several indicators like the type and number of microorganisms, the type and 
amount of organic material that protect the microorganisms, the number and the size of 
cracks on the device which might be observed during sterilization procedure, and all 
these can represent the effectiveness of each sterilization method.
[11]
 
According to ISO 11139:2006 Sterilization of health care products, the capacity of 
each sterilization method is defined as sterility assurance level (SAL). It is the probabil-
ity of a single viable microorganism occurring on an item after sterilization. The term 
SAL takes a quantitative value, generally 10
-6
 or 10
-3
. When applying this quantitative 
value to assurance of sterility, an SAL of 10
-6
 takes a lower value but provides a greater 
assurance of sterility than an SAL of 10
-3
.
[12]
 
2.1.2.1 Steam autoclave and dry heat sterilization  
As the oldest method, autoclave still plays an important role in medical industry due to 
its safety and cost efficiency. By applying hot steam under atmospheric pressure, one 
sterilization cycle can generally be done within half an hour.
[13]
 Two common types of 
autoclave are differed by different method of removing air from chamber and steam 
channelling. Gravity-displacement type is done by the pressure that steam-entering 
chamber exerts on and displace air; while pre-vacuum type removes air by a vacuum 
pump while steam is injected into the chamber simultaneously.
[13]
 Table 2 summarizes 
the processing parameters for each cycle. 
Table 2: Cyclic parameters of autoclave sterilization
[13]
 
Dry heat sterilization is a choice when the substrate is sensitive to moisture. In the 
condition that the steam and ethylene oxide gas cannot penetrate, such as anhydrous oils, 
petroleum products, and bulk powders, this method in a form of hot air can be applied 
as well. Due to the absence of moisture, the microorganism is destroyed via a slow pro-
cess of heat absorption by conduction which results in a longer cyclic time (at least two 
hours) and higher temperature (160-170°C).
[13]
 Due to these hazard parameters, its ap-
plicable use is limited. 
Configuration Temperature Time 
Gravity-Displacement 121-123 °C 15 - 30 minutes 
132-135 °C 10 - 25 minutes 
Pre-vacuum 132-135 °C 3 - 4 minutes 
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2.1.2.2 Ethylene oxide (EtO) Sterilization 
In 1950’s, ethylene oxide (EtO) was introduced as an effective, low temperature chemi-
cal sterilization method. It is completed in the 50-60°C range as a cycle of 16-18 
hours.
[13]
 As a chemical agent that kills microorganisms, including spores, EtO must 
have direct contact with microorganisms on the sterilized item. Due to high ignitability 
and explosibility of EtO, an explosion-proof chamber in a controlled environment is 
essential to carry the sterilization out.
[13]
 
W. J. Greaves Walker, et al. reported that it was never permissible to regard EtO as 
practically non-poisonous.
[14]
 For this reason, the EtO sterilized device must be pack-
aged with wraps and be aerated. The aerated time should be long enough to ensure the 
safety for handling and end using.
[13] 
2.1.2.3 Irradiation sterilization 
Irradiation sterilization eliminates microorganisms via causing microbial death or indi-
rect chemical reaction with an ionizing radiation. This sterilization method has effects 
on cells and microorganisms depending on three factors: wave-length, dosage, and ex-
posure time. The first use of ionizing radiation can be traced back to 1895 and the 
method patented in 1921.
[11]
According to European Pharmacopoeia, the reference dose 
of 25 kGy is enough to achieve a sterility assurance level (SAL) of 10
-6
, without any 
significant rise in temperature.
[15]
  
One key parameter of irradiation sterilization is the dose uniformity ratio (DUR) 
which is a ratio between the maximum and minimum dose needed to process a product 
effectively. Due to some plastic and elastomer are sensitive to irradiation, an optimal 
DUR can prevent unacceptable levels of degradation. Thus DUR is a parameter that 
must be taken into consideration during sterilization method selection.
[16]
 
At the present, the three main irradiation methods, gamma, X-ray, and e-beam, are 
differed by irradiation mechanism: radioactive source or electrical source, as shown in 
Figure 2. The different natures of sources has attributed distinguishable advantage and 
limitation of each method.
[16] 
As a highly penetrating and commonly used sterilization method, gamma irradiation 
is generally used for sterilizing gaseous, liquid, and solid materials, homogeneous and 
heterogeneous systems and disposable medical equipment. In pharmaceutical field, both 
active pharmaceutical ingredients (API) and the final dosage forms can be sterilized by 
gamma irradiation sterilization. Gamma rays are generated with the self-disintegration 
of Cobalt-60 (
60
Co) or Cesium-137 (
137
Cs); and it can be applied on many materials 
except PVC, acetal and PTFE.
[11]
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Figure 2: Three main irradiation sterilization method: electrical source and radioactive 
source
[16] 
E-beam irradiation method is made by obtaining e-beams from accelerator. Admit-
ted as a safe, non-emissive, and high speed processing, e-beam has been attracting more 
attention recently in medical device industry. Accordingly, electron-beam dose-rates are 
much higher than gamma resulting in significantly reduced exposure times (gamma 
irradiation: 10 to 20 hours exposure
[13]
; e-beam: 15 minutes
[11]
). E-beam is by far the 
cheapest sterilization technology, as well as the most energetic efficiency
[16]
, shown in 
Figures 3 and 4. If products are compatible, e-beam is the preferred method. Typically, 
high energy e-beam sterilizes products are packaged in boxes. 
 
Figure 3: X-ray product sterilization costs decrease faster than gamma when production 
increases, while the e-beam is the most costless one
[16]
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Figure 4: Energy efficiency comparison of each irradiation sterilization method
[16]
 
With a better penetration than e-beam and higher cost efficiency than gamma, X-ray 
radiation provides an alternative choice when the product wall thickness is incompatible 
with the e-beam. However, it is not an officially accepted sterilization method for drugs 
and reused medical devices.
[11]
  
The penetration depth of e-beam has limited its application. A comparison of pene-
tration depth between gamma and e-beam irradiation in same medium is shown in Fig-
ure 5. 
 
Figure 5: Dose vs. depth comparison of e-beam and gamma sterilization
[17]
 
This graph illustrates the more limited penetration (over gamma) of the e-beam, and 
this curve is valid for most plastics and objects with the similar density of water. Elec-
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tron beams penetrate only about 6 cm in water with normalized dosage, 10 MeV, and 
about as deeply into 70% isopropyl alcohol/30% water solutions, since the densities are 
about the same. The dose from gamma irradiation is 60% of the surface dose at the 
depth where the electron beam dose is virtually zero.
[17]
 
The selection among irradiation sterilization method is mainly based on four aspects: 
1) homogeneity layout in their packaging; 2) material / polymer resistance to irradiation; 
3) penetration needs; 4) sensitivity of the products. Generally, the preferred method is 
implied by the raw material supplier.
[16]
 However, the product design may influence the 
selection by changing geometric dimensions. A general decision pathway is shown in 
Figure 6 to help the selection procedure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Decision tree for irradiation sterilization method selection
[16]
 
Following this procedure, the suitable irradiation sterilization method for certain 
product can be identified. 
Start 
No 
YES 
Are products 
laid out homo-
geneously in 
their packaging? 
High What is the 
product re-
sistance to 
radiation (dose 
max)? 
Low 
Is high penetration 
required to pene-
trate products or 
packaging? Low 
Are products fragile or 
sensitive to irradiation 
(coloration, oxidation...)? 
E-beam 
High 
YES X-ray 
No 
X-ray or Gamma 
Homogeneous 
Irradiation 
resistance Penetration needs 
Sensitive 
products 
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2.1.2.4 Comparison and selection of sterilization methods 
Each sterilization method has its limitation, so that there is no absolutely ideal one. Ta-
ble 3 shows the general advantage and disadvantage of each method. However, as the 
technology moving on, the new sterilization method might arouse and the weakness of 
existed method can be improved. Therefore, this table of comparison can only be used 
for general consideration. 
Table 3: Sterilization methods comparison table
[11]
 
According to Table 3, the material sensitivity, cost efficiency, sterilization batch ca-
pacity should be taken into consideration. More generally, the rules for sterilization se-
lection have been defined as per Decision Trees for the Selection of Sterilization 
CPMP/QWP/054/98, shown in Appendix 1.
[18]
  
According to ISO standard, the term terminal sterilization refers the process where-
by the product is sterilized within its sterile barrier system.
[30]
 Hereafter, this term is 
used for this certain case. 
The products which intend be sterilized, should be sterilized to clear state in their fi-
nal containers. It ensures not only the product per se, but also the entire packaging sys-
Method Advantage Disadvantage 
Pressured vapor sterilization 
(Autoclave) 
 Maturely  commercialized  
 Nontoxic and safe for the 
environment 
 Short processing time 
 Harmful to heat and mois-
ture sensitive material 
Dry heat sterilization  Non-toxic and safe for the 
environment. 
 Absence of moisture 
 Long processing time 
 High heat 
Ethylene oxide (EtO) sterilization  Maturely  commercialized 
 Moderate temperature 
 No limit for lumen 
 Complete penetration de-
pending on the use of the 
permeable gas. 
 Long processing time 
 Flammable, and explosive 
 EtO is toxic and  carcino-
genic, aeration period is re-
quired 
Gamma radiation sterilization  Maturely  commercialized 
 High SAL guaranteed  
 Easy to control  
 High penetration depth 
 Long processing time 
 Expensive set-up 
E-beam sterilization  Maturely commercialized 
 Short processing time 
 High SAL guaranteed 
 Easy to control  
 Cost efficiency  
 Low penetration depth 
 Expensive set-up 
X-ray radiation sterilization  Highest penetration depth 
 High SAL guaranteed 
 Easy to control  
 Not commercialized yet 
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tem is sterile before open/use. The final result is to achieve no more than 10
-6
 SAL level, 
by all means. Except the common sterilization method, which including autoclave, dry 
heat, and irradiation, the formulation filtration and aseptic processing are options as well 
in some extreme cases. Commercial considerations should not be used as justification 
for not using terminal sterilization with the highest level of sterility assurance.
[18]
 
The validation of sterilization is obtained by microbial load determination (bio-
burden) and sterility testing, before and after sterilization respectively according to ISO 
11737-1 and -2.
[19]
 The bio-burden test, shown in Figure 7, is aiming to determine the 
number of viable bacteria on the product before sterilization. Meanwhile, the test proce-
dure should be conducted via valid tests steps. 
 
Figure 7: Description of pre-sterilization bio-burden test
[19]
 
After sterilization, the sterility test is applied to detect the presence of viable bacteria 
on the product (Figure 8). The common used test mediums are trypticase soy broth 
(TSB) and thioglycollate broth with resazurin (TBR) according to standards.
[19]
 The 
number of tested samples is decided by consultants as per ISO 11737-1 and -2. 
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Figure 8: Description of sterility test
[19]
 
The assessment of proliferation can be done via outsourcing or by manufacturer it-
self. A rapid testing might be achieved by ready-to-use consumable biological indicator 
under professional instruction. 
2.2 Feasible analysis for production 
When design paper is delivered to manufacturer, the staffs start to analyse the essential 
productive elements. To meet the requirements by the nature of products, proper materi-
al and processing methods selection is the key to achieve functionality of product. Fol-
lowing with design of experiments to conjecture possible problems in real practice and 
make revision, a reliable and effective production plan can be established eventually. 
2.2.1 Material and processing method selection 
By well-defined requirements, locating the suitable material solution for medical device 
is taken design, processing and performance demands into consideration simultaneous-
ly.
[20]
 Briefly, the summary of material and manufacture processing selection is shown 
in Table 4. 
Material characterization refers to composition, mechanical property, thermal prop-
erty, and electrical property if applicable. The middle column in Table 4 lists the re-
quirements shared by material and processing method selection. The polymeric material 
offers a good flexibility to design, easy fabrication and sterility integrity
[1][43]
; however, 
it raises difficulty for selection due to the ever changing formulation development and 
variety unless the inventor appoints the certain material. Material and processing meth-
od compatibility with the plant’s existing manufacturing systems is a reasonable entry 
point. 
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Table 4: Material and processing selection criterion
[20]
 
2.2.2 Design of experiments 
In the industry, the term: design of experiments (DOE) refers an effective method that is 
to apply a computer-enhanced, systematic approach to experimentation, one that con-
siders all factors simultaneously. Rather than a trial-and-error manner which may ne-
glect something through testing one factor at a time while holding other factors constant, 
DOE provides information about the interaction of variants and the way the total system 
works.
[21]
 In this study, polymer manufacturing industry in particular, a DOE analyses 
the whole production procedure, including pre-processing, in-processing and post-
processing treatment, by varying the parameters in each stage.
[28]
 This DOE may in-
volve complicated mathematical modelling, statistic calculation and computer software 
assistance which is not the concern of this study; instead, all the changeable parameters 
are considered and discussed. 
2.2.2.1 Pre-processing treatment 
To fulfil the device design requirement, additives and modifiers are often introduced 
into polymers due to the property limitation of certain polymeric materials. By incorpo-
ration with additives, the properties of formulated plastics and elastomers can be tai-
lored to provide a better processing and end performance.
[22]
 For example, rigid polyvi-
nyl chloride can be made flexible with the addition of plasticizers; the strength of some 
polymers can be enhanced by mixing with glass fibre; flame retardant can reduce the 
risk of flammable material;
 [23]
 the introducing of tungsten powder can decrease the pro-
tein absorption on the surface
[64]
, etc. 
Many additives like fillers, toughening agents, lubricants, and stabilizers can be used 
to improve the physical and mechanical properties. Other properties are modified by 
more specific additives such as radiopaque additives; nano-additives can be used in 
small amounts to produce miniature parts and devices that are strong and that incorpo-
rate functional characteristics like electrical conductivity, barrier property, radio-opacity 
Materials selection  Manufacturing processing 
 Mechanical characterization 
 Shelf life and dimensional 
stability 
 Optical clarity 
 Water vapor transmission 
Rate, O2 and CO2 barrier 
 Material aging 
 Biocompatibility 
 Chemical resistance 
 Leachables and extractables 
 Environment friendliness 
 Lot-to-lot consistency from 
resin supplier 
 Supplier technical service 
 Processing requirement; 
Extrusion /molding/ ther-
moforming, etc. capability 
 Product components as-
sembly 
 Compatibility with the 
plant’s existing manufactur-
ing systems 
 Cost 
 Sterilization methods and 
sterilization resistance 
 Wide processing operation 
window 
 Large-scale manufactura-
bility 
 High production output 
rate 
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and antimicrobial properties. Stabilizers can be used to improve thermal and radiation 
resistance. 
Additives which should be mixed before processing, the homogeneous dispersion or 
laid out is crucial. Additives can be incorporated into the polymer at several stages:  
1) During the polymerization, which the ready-to-process compounding can be 
purchased directly; 
2) Addition to the raw granulates in pre-processing treatment; 
3) In-processing stage; 
4) Finishing stage on the product surface.[23] 
Additives such as stabilizers are often introduced by raw material supplier, whereas 
performance-critical additives such as fillers, flame retardants, anticoagulation agents 
are usually mixed at the compounding stage by device manufacturer via a blender or 
milling machine.
[23]
 The blending ratio is usually provided by supplier, however, some 
fillers amount and orientation (lay-out) should be adjusted by user to meet specific pur-
pose. While, the leaching, migration, evaporation and degradation are main issues to be 
considered which may have potential health risks.
[24]
 New approaches are under devel-
opment along with the ever developing of polymer technology.  
Biocompatibility is the priority of selection of additives. The hazard ingredients 
which cannot match the safety of final products designation are absolutely banned. 
Meanwhile, the controversial additives are recommended to be replaced by proven safe 
alternates if possible. The phthalates, used as plasticizer and solvents, are intensively 
studied due to the ubiquitous exposure to population and may cause endocrine disorder; 
bisphenol A, which can be found in epoxy resins, polyester styrene, and polycarbonate, 
has oestrogenic properties that may influence hormone level; polybrominated diphenyl 
ethers, a commonly used flame retardant added to a variety of consumer products, is 
considered pervasive endocrine-disrupting environment contaminants of concern.
[25]
 
These controversial additives are still under investigation with more updating infor-
mation. 
Due to moisture sensitivity of both polymer and additives, sometimes, the sufficient 
drying is applied to ensure the optimal quality and yield. Excess moisture in plastics 
decreases the strength of the product and causes a poor finish on the surface. The need 
to dry the plastics depends on the storage conditions of raw material and plastic type. 
Raw material stored in their unopened original packages is considered to be specifically 
dried unless the drying is required by supplier. The opened materials should be stored in 
a clean, dry, and even aseptic environment if applicable. 
For hygroscopic polymers, such as PET and nylon which are engineering plastics, 
the drying process is challenging because of the internal moisture that is absorbed into 
pellet’s or fibre’s structure. Effective drying demands that the raw material is warmed 
up and then exposed to dry air in order to drive off the internal moisture; and during 
processing, dehumidifying device such as desiccant dryers are used. In contrast, the 
whole pellet is not required to be heated for non-hygroscopic materials, such as PP and 
PE. Drying of those materials can be done by exposing to heated air with hot air dryers 
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to dehumidify the surface moisture from recycling or stored environment.
[26]
 It is 
strongly recommended that the raw material supplier is consulted for drying recommen-
dations. 
Desiccant dryer is the most commonly used dehumidifying device; and its ability to 
produce dry enough air even for the most hygroscopic materials is highly appreciated. 
Meanwhile, using a dehumidifying dryer with non-hygroscopic plastics can provide 
benefits for the user, for instance, some weather related problems with drying can be 
minimized. The dewpoint range for produced dry air ranges from -10 to -40 °C, even 
down to -60 °C, depending on the dryer type and application.
[26]
 The operating principle 
of desiccant dryer is quite simple as shown in Figure 9. 
 
Figure 9: Principle of desiccant dryer
[26]
 
As an indicator of the quality of dry air produced in desiccant dryer, dewpoint 
should be maintained at a certain level depending on plastics.
[26]
 In order to achieve 
most reliable data about dryer performance, the dewpoint transmitter is installed before 
the hopper, illustrated in Figure 9. 
2.2.2.2 In-processing parameter 
Although some processing parameters and methods are recommended by raw material 
supplier, this limited information is too general and limited to apply on a specific appli-
cation. The molding parameters may influence the dimension and microstructure of 
products directly. These parameters may include additive compounding ratio, feeding 
speed, barrel temperature, screw speed, nuzzle character, shear rate (depends on the 
rheology property of material), switchover and holding pressure, cold or hot runner, 
mold temperature, packing time, cooling time and demolding treatment (draft angle, 
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etc.). The conventional, experience based trial-and-error method is not only money and 
time consuming, but also hard to accumulate and pass down the experience. Moreover, 
there were many uncertain variables besides the working conditions during processing, 
such as the disturbance of the materials, the influence of ambient temperature etc., 
which all might influence the product quality.
[27]
 
By the purpose of DOE to find out an effective to analyse the production parameters 
thoroughly, Fu-Chen Kung, et al. have reported an optimization research based on 
Taguchi method and grey relational analysis.
[27]
 The data were produced by injection 
molding to find out the optimal level of thin wall part with sufficient tensile strength. 
The factors which influence on the dimension of thin wall part significantly are injec-
tion pressure, injection speed, screw speed, and cooling time. While, the tensile strength 
of thin wall part is affected by pre-plasticity amount, injection speed, packing time and 
cooling time. The experiments were conducted five times, and results have proved the 
reproducibility and reliable (the values all fell within 95% confidence interval). It veri-
fied that an optimal processing parameter combination of thin wall part can be received 
via using grey relational analysis and Taguchi method. Expectedly, this method is appli-
cable for optimization of other processing approach. 
Meanwhile, the product design is not always feasible to precise fabrication; there-
fore, some details should be refined in real production practice. Plastic parts have a ten-
dency to wrap and sink in certain areas, and this is usually overcome by introducing a 
groove between thick and thin area.
[28]
 A groove functions as a ‘defect’ that release the 
imbalance warpage nature of thick and thin are in order to ‘lift’ the sinking tendency.    
One example is the difficulty to produce a part with an unsupported wall to remain per-
pendicular. As shown in Figure 10 (a), a groove can be added that removes the thick 
area created at the intersection of the perpendicular and main where a supporting rib 
cannot be designed. A thick area stays hotter for a longer period of time in mold, which 
increased shrinkage in the part and pulls the wall inward. Another example is shown in 
Figure 10 (b) that a large-diameter boss with walls for threaded inserts or screw holes 
for self-tapping screws often too thick to support. A same type of groove feature than 
Figure 10 (a) can be made around the boss to prevent sinking. 
 
Figure 10: Left (a), an unsupported wall; Right (b), a large-diameter boss
[28]
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2.2.2.3 Post-processing treatment 
The ‘post’ here refers to the timing after mold opening, and before parts assembling. 
Rather than metal parts are machined into required precision and tolerance, plastic is 
usually one-step molded except overmolding. This gives plastic the advantages of cost 
and time efficiency and high production rate; however, the challenge of precise mold 
design and processing control is raised as well. Usually, mold flash of thermoplastic can 
be avoided by accurate volumetric filling of the cavity. Considering of thermosets such 
as silicone rubber, however, it is difficult to prevent the flash due to complicated in-
mold curing procedure.
[67]
 In consequence, the trimming is used for these parts. 
An attempt has been made by E. Haberstroh et al. to simulate the filling procedure 
of liquid silicone rubber (LSR) to achieve the most efficient mold cavity filling.
[29]
 A 
specific software, ‘2-1/2-D-simulation software based on FEM using the control volume 
method of Osswald’, is used for processing simulating investigation. The filling phase is 
divided into two steps: 1) the first step is filling the mold to 91% of the volume; 2) the 
second step is called dilation phase where the cavity is filled completely by the thermal 
expansion of LSR. The higher filling degrees can be applied to increase processing sta-
bility. Nevertheless, the higher filling degree results in higher cavity pressure. The up-
per limit is 300 to 500 bar according to the mold rigidity as well as design of parting 
surface.
[29]
 
After the processing, a correct washing is applied to products to remove the possible 
processing agent and other surface contamination. The washing can be done in industry 
washing device, and powered by ultrasonic.
[118]
 Subsequently, products are dried under 
suitable time, pressure and temperature. 
In conclusion, the DOE procedure is an evaluation of production feasibility and an 
improvement of technical details. Figure 11 covers, but are not limited to, considerable 
parameters. 
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Figure 11: Parameters of polymeric medical device production 
2.3 Packaging and labelling 
The packaging design and material selection are part of the whole production analysis. 
Depending on the product dimension, statement (gas, liquid or solid), sensitivity, sterili-
zation method, shelf life and transportation way, that according to ISO 11607: packag-
ing for terminally sterilized medical devices, the design of packaging is varying all the 
time. A packaging design e.g. for contact lenses is completely different than a scalpel 
handle. When the product is required to be terminally sterilized, it always means the 
product should be presented aseptically within packaging system for the end-user.
[30]
 
Due to the specific nature of medical device, the choosing appropriate materials for 
terminally sterilized medical device packaging systems is influenced by the interrela-
tionships that are illustrated in Figure 12. 
 
 
 
 
 
 
 
 
Figure 12: Interrelationships influencing the choice of appropriate materials for termi-
nally sterilized medical packaging system
[30]
 
Pre-
processing 
•Additive mixing 
ratio 
•Drying 
In-processing 
•Additive mixing ration 
•compounding ratio 
•feeding speed 
•barrel temperature  
•screw speed  
•nuzzle character 
•shear rate  
•switchover and holding 
pressure 
•cold or hot runner 
•mold temperature 
•packing time 
•cooling time  
•demolding treatment (draft 
angle,etc) 
•Specific design (e.g. groove)  
Post-
processing 
•Excess trimming 
•Washing 
Medical device 
Packaging system 
design and process 
Sterilization process(es) 
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If the device is intended to be terminal sterilized by EtO or steam, the sterile barrier 
system has a permeable component to allow the sterilizing gases to enter, kill the mi-
croorganisms, and escape without significant residual concentrations.
[30]
 If the device is 
to be terminal sterilized by irradiation, a permeable component may not be required and 
the sterile barrier system can be made entirely of impermeable materials.
[30]
 In addition, 
Lecon Woo, et al. have reported that the e-beam is, generally, less harmful to polymer 
than that of gamma radiation because of shorter processing time.
[31]
 
There are many types and variations of sterile barrier systems used to package ster-
ile medical devices, such as pre-formed rigid tray and a die-lid, flexible peel pouch, 
sterilization bag, header bag, form/fill/seal (FFS) process, and four-side-sealing (4SS) 
process.
[30]
 The ultimate goal of  a sterile barrier system is providing  microbial barrier 
properties, and sufficient protection under certain storage and transportation within shelf 
life, subsequently, ensuring a aseptic and valid presentation of device for end user.
[30]
 
The requirements on materials referenced shall apply to those used in pre-formed 
sterile barrier systems, as well as sterile barrier systems.
[30]
 According to ISO 11607, the 
packaging material selection is similar to material selection mentioned in this study in 
previous chapter.
[30]
 It is noticeable that the packaging and labelling material and com-
ponent, e.g. coatings, ink, or chemical indicators, shall not adversely affect the medical 
device by reaction, contamination and/or transfer before, during or after the defined 
sterilization process.
[30]
 Beside the design requirements listed in ISO 11607, another 
aspect is the reinforcing attachment where the highly durable environment required de-
vice is packaged, a rigid plastic tray may be used.
[32]
 
The testing of packing is given in ISO 11607 as follow,  
“Integrity of sterile barrier system shall be demonstrated after sterilization and 
subsequent performance testing. Physical tests, along with microbial barrier testing of 
porous packaging materials, can be used to establish the capability of the sterile barrier 
system to maintain sterility. Standardized test methods for evaluating the integrity of the 
sterile barrier system are preferred. However, in the absence of applicable validated 
sterile barrier system integrity tests, microbial barrier performance characteristics can 
be established by testing the microbial barrier properties of materials and the integrity 
of the seals and closures.”[30] 
The following, but not limited to, are some practical tests:
[33] 
 Internal pressure 
 Dye penetration 
 Gas sensing 
 Vacuum leak 
 Seal strength 
 Transportation simulation 
 Accelerated aging 
 Microbial barrier 
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Meanwhile, a stability testing, which is a different entity form performance testing, 
shall be launched to demonstrate the sterile barrier system integrity maintenance over 
time.
[30]
 
Figure 13 shows a commercialized packaging product by Merrill’s Packaging, USA. 
It is custom designed with snap features to protect delicate components. This ther-
moformed PETG heat sealable tray is paired with a Tyvek lid for EtO sterilization.
[34]
 
 
Figure 13: Packaging of medical procedure tray kit
[34]
 
The labelling of medical device is regulated by Global Harmonization Task Force 
and FDA, which include format, content; and the used symbols are defined in ISO 
15223.
[35][36]
 An example of labelling which is valid in EU and the USA is illustrated in 
Figure 14. The label contains information about the product name, expire date, refer-
ence and lot numbers, manufacturer information, bar code, details about the item, and 
an illustration of the item. The meaning of symbols can be found in ISO 15223:  Medi-
cal devices — Symbols to be used with medical device labels, labelling and information 
to be supplied.
[36]
 
 
Figure 14: Example of what a unique device identification (UDI) could look like on a 
medical device label
[37]
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2.4 Regulatory issues 
In order to achieve valid production of medical device, the processing and quality con-
trol should be under the consulting which related to regulatory issues. ISO 10993 is a 
series of standards that detail all characterization and biocompatibility tests needed for 
medical grade materials and medical devices before clinical studies.
[38]
 This standard is 
recognized in both Europe and the United States (FDA version) as well as in China. The 
details all relevant biological tests needed for the material/device evaluation protocols 
are given in ISO 10993-1; and the subsequent standards are more specific to the type of 
biocompatibility or toxicity tests. The characterization tests needed for plastics of medi-
cal purpose are given in ISO 10993-18.
[38]
 The necessity of biocompatibility tests of 
material/device can be decided by the decision tree shown in Figure 15. Biocompatibil-
ity tests of medical device are required according to contacted condition with the human 
body. The type and degree of testing will differ depending upon the extent and location 
of contact. Generally, the tests are decided by consultant and out sourced by a qualified 
institution. Existing data might be sufficient for submission if they are scientifically 
valid.
[38]
 In a nutshell, no biocompatibility test needs to be applied when both material 
and device (includes packaging and sterilization) are exactly as same as existed com-
mercialized product. Otherwise it is necessary to assess whether and what test protocol 
should be followed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: ISO 10993 Biocompatibility evaluation decision tree for material/device
[38]
 
Start 
Does the de-
vice/material 
contact the body? 
No 
Biocompatibility 
tests not required 
Yes 
Material 
Characterization 
Is the device/material 
the same as an exist-
ing commercially 
available product? 
Yes 
Does the device have 
similar properties to 
an existing commer-
cial product? 
No Sufficient justifica-
tion and/or test date 
available? 
Final review and 
assessment  
Yes 
Yes 
Perform appropriate biocompatibility tests as per ISO 10993 
No No 
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The term biocompatibility is the interaction occurring by a material/device contact-
ing with skin, tissues, or biological fluids for defined or extended periods of time. The 
materials which have no effect on the composition, function or safety of the biological 
systems in the patient are required to achieve good biocompatibility. The biocompatibil-
ity of a medical device depends upon its nature and composition of material, the design 
of the device, the contact nature with patient, the duration time of contact and the tem-
perature during contact.
[38]
  
Table 5: ISO/FDA/MHLW test chart
[39]
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Biological effects include: cytotoxicity; sensitization; irritation/intracutaneous; sys-
temic toxicity; subchronic toxicity; genotoxicity; implantation, and hemocompatibility. 
These factors are indicators for biocompatibility tests as well. The coverage of these 
factors is lying on the intended purpose of device, accordingly.
[119]
 
A summary of different biocompatibility tests that should be applied is shown in 
Table 5, which the different requirements are given as well according to the regulations 
of ISO, FDA and Japanese Ministry of Health, Labour and Welfare (MHLW). 
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3. CLASSIFICATION OF MEDICAL DEVICES 
A classification of medical devices is necessary to sort the products into certain groups 
systematically to order to identify the according regulation, processing file, and tests 
efficiently. In this study, the classification is based on the material, reuse or disposable 
nature, and application. 
3.1 Biomaterials 
The first definition of the term biomaterials was committed in 1987 by European Socie-
ty for Biomaterials and some consistency was achieved.
[40]
 However, the ever evolution 
of material science and health technology has raised confusion and disarray within new 
area, such as drug and gene delivery systems, tissue engineering and cell therapies, or-
gan printing and cell patterning, nanotechnology based imaging and diagnostic systems 
and microelectronic devices, by the old definition. In result, a refined definition is pre-
sent: 
“A biomaterial is a substance that has been engineered to take a form which, alone 
or as part of a complex system, is used to direct, by control of interactions with compo-
nents of living systems, the course of any therapeutic or diagnostic procedure, in human 
or veterinary medicine.”[40] 
In this study, the metal, ceramic and glass, synthetic polymer and composite used as 
biomaterials are discussed, respectively. 
3.1.1 Ceramic and glass 
Although ceramics and glass had been regarded as brittle materials whose range of ap-
plications were constrained by their relatively poor mechanical properties historically, 
advances in processing technology and a deeper understanding of structure and proper-
ties of ceramic and glass have led to the expansion of their capability into a whole host 
of different areas. The high melting point of ceramic and glass is advantage in engines 
and turbines at elevated temperatures. With improved toughness, they have been intro-
duced into body armor design as a consequence.
[41]
 
With excellent wear resistance, high compressive strength properties, pleasing aes-
thetic appearance and proven biocompatibility, ceramic and glass are attractive candi-
dates for biomedical application. Known as bioceramics, they are now used extensively 
in many different areas of medicine to augment or replace parts of the body. For exam-
ple, alumina and zirconia are used to fabricate components of hip joint replacements; 
 27 
hydroxyapatite (HA) and glass ceramics are used as coatings on prosthetic stems.
[41]
 
The successful applications are countless and still expanding. 
3.1.2 Metallic material 
The favorable properties such as toughness, good fracture resistance, electrical conduc-
tivity and formability as well as the well-established and widely available manufactur-
ing techniques (e.g. casting, forging, machining), have promoted metal use in medical 
area. Besides the common medical instruments, metal and alloys are extensively used in 
the fields of orthopedics and dentistry primarily. The applications of metal and alloy 
have been expanded to cardiovascular devices (e.g. artificial heart valves, blood con-
duits and other components of heart assist devices, vascular stents), and neurovascular 
implants (aneurysm clips). In addition, the good electrical conductivity of metals favors 
their use for neuromuscular stimulation devices, the most common example being car-
diac pacemakers.
[42]
 
3.1.3 Polymeric material 
Polymers have been employed in every aspect of medical device industry for many 
years.
[43]
 Biopolymers based on medical applications can be categorized into three 
groups, namely inert, bioactive and biodegradable polymers. Each category of this clas-
sification comprises natural and synthetic polymers. The inert polymers suit very well 
with some applications that are aimed to last for a lifetime, such as breast implant poly-
mer, or extracorporeal material. While, if the purposed functionalization time of the 
product is just for a certain period of time, e.g. one year or so, the biodegradable poly-
mers are considerable choices. 
3.1.4 Composite material 
Bone, wood, dentin, cartilage and skin, which often exhibit hierarchical structures in 
which particulate, porous, and fibrous structural features are seen on different micro-
scales, are natural composites. In general, composite materials are solids which contain 
two or more distinct constituent materials or phases, on a scale larger than the atomic. 
Composite materials offer a variety of advantages in performance, which highly de-
pending on the structure, comparing with homogeneous materials. There is the potential 
for stiff, strong, lightweight materials as well as for highly resilient and compliant mate-
rials.
[44]
 
In biomaterials, it is important that each component of the composite is biocompati-
ble. Moreover, the interface between components should not be degraded by the body 
environment via contacting with patient for certain level and time. Dental filling com-
posites; reinforced methyl methacrylate bone cement, and ultra-high molecular weight 
polyethylene; and orthopedic implants with porous surfaces are good examples of com-
posites for medical applications.
[44]
 In addition, coating is sometimes regarded as com-
posite as well. 
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3.2 Disposable versus reusable 
There are two distinctive different medical devices: disposable ones and reusable ones. 
The disposable devices are designed to be discarded after use; while the others are being 
cleaned and reused on the same patient or on different patients. The common concern 
for both of them is the cleanliness and sterility of the device and the subsequent safety 
to the patient till the first contact. There are two more basic safety concerns with reusing 
medical devices over disposable ones. First is the effecting of cleaning, disinfection, and 
sterilization on the chemical, physical, and mechanical integrity of the device.
[45]
 Usual-
ly, the disposable devices are terminally sterilized with packaging by irradiation method; 
while the autoclave is commonly applied on reusable devices in hospital as well as 
washing and disinfection.
[28]
 Apparently, this issue should be taken into consideration in 
material selection. The second concern is providing safety for the personnel who are 
responsible for cleaning, disinfecting, or re-sterilizing the device.
[45] 
In other words, the 
personnel should be well informed about the potential risk of reusing these devices. For 
example, a container which may trap some body fluid such as blood inside, the incorrect 
opening and contacting of this container would lead to an infection threat to the person-
nel. Meanwhile, the design of reusable devices should ease the reprocessing procedure. 
3.3 Classification by applications 
According to Directive 93/42/EEC, the classification of medical devices is essential for 
the purpose of the conformity assessment procedures. The four products classes, Class I, 
IIa, IIb and III, are based on the vulnerability of the human body taking account of the 
potential risks associated with the technical design and manufacture of the devices.
[46]
 In 
Directive 93/42/EEC, the classification of invasive time of devices is one factor to de-
fine. The term Transient refers to continuous use for less than 60 minutes; Short-term 
refers to continuous use for not more than 30 days; Long-term refers to continuous use 
for more than 30 days.
[47]
  
The classification of devices is depending on the inventor, whose power is to decide 
the purpose of a device. For the manufacturer, the concern is of the requirements that 
each class relates. The Class I have low level of vulnerability associated with these 
product; whereas, for Class IIa devices, the intervention of a notified body is compulso-
ry at the production stage; for devices falling within Classes IIb and III which constitute 
a high risk potential, inspection by a notified body is required with regard to the design 
and manufacture of the devices; while Class III is set aside for the most critical devices 
for which explicit prior authorization with regard to conformity is required for them to 
be placed on the market.
[46]
  
In the area where the FDA guidelines are applied, the classification of medical de-
vices is falling into Class I, II, and III with different definitions. In general, Class I de-
vices present minimal potential harm to the user with simple design, manufacture and a 
history of safe use. Class II are devices where general controls are not sufficient to as-
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sure safety and effectiveness and existing methods/standards/guidance documents are 
available to provide assurances of safety and effectiveness. Class III medical devices 
have the most stringent regulatory controls, which usually support or sustain human life, 
are of substantial importance in preventing impairment of human health, or present a 
potential unreasonable risk of illness or injury to the patient.
[48]
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4. POLYMERIC MATERIALS IN MEDICAL FIELD 
The superior design flexibility of polymeric material, comparing to metal, ceramic and 
glass, makes it an excellent candidate for medical application. They can be processed 
into myriad shapes, sizes, thicknesses, and colors, and their properties can be tailored to 
meet a wide range of physical, mechanical, chemical, and biocompatibility requirements. 
In addition, the additives and fillers can be used to render plastics flexible or rigid, insu-
lating or conductive, hydrophilic or hydrophobic, transparent or opaque, and chemically 
resistant and sterilization resistant. Meanwhile, the processing methods can vary to meet 
the production requirements. The lightweight, balanced of strength, stiffness, toughness, 
ductility, and impact resistance of polymeric material give the designer a broad range of 
options for both performance and cost efficiency orientation.
[43]
 
4.1 Silicone rubber 
As shown in Figure 16, silicone is a group of polymer that backbone is composed by –
O–Si–, and the substituent group R can be methyl, ethyl, phenyl, etc. 
 
Figure 16: Backbone of silicone rubber
[3]
 
Polydimethylsiloxane (PDMS), which R is methyl, based elastomers have been used 
in a wide range of biomedical application in the past three decades, as a result of their 
physiological inertness, good hemocompatibility, low toxicity, good thermal and oxida-
tive stability, low modulus and anti-adhesive properties.
[49]
 When R is ethyl, polydieth-
ylsiloxane (PDES) is tasteless, odorless, and essentially non-toxic, non-irritating, and 
non-sensitizing; meanwhile offers improved compatibility with better surface lubrica-
tion property, pigment wetting, skin feel over PDMS.
[50]
 While the R is phenyl, polydi-
phenylsiloxane (PDPS) has higher thermal and thermo-oxidative stability than PDMS 
and PDES. However, the difficult processing is caused by the high isotropic molten 
temperature which is around 560 °C that much higher than decomposition temperature. 
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To solve this problem, a PDPS-PDMS-PDPS triblock copolymer is introduced.
[51]
 The 
raw silicone rubber can be either liquid state or solid state, and the liquid silicone rubber, 
LSR, is the main object in this study. Among different batches of LSR, RTV refers 
room temperature vulcanized category while high temperature vulcanized ones are HTV. 
4.1.1 Properties of liquid silicone rubber 
There are many commercialized LSR suppliers, and the properties are varying to meet 
different requirements. The data in this study is obtained from Wacker, a worldwide 
silicone solution provider in Germany. And all the material batches are FDA approved. 
Most of the LSR raw materials are served in two components form, A and B, which B is 
containing curing agent. While, there is one component ready-to-use batch such as Sil-
puran
®
 4200.
[52]
 It is an adhesive which cures at room temperature under the influence 
of atmospheric moisture. 
The mixing of component A and B should be thoroughly by specific accessory on 
processing machine. The mixing timing is well instructed by supplier especially for 
RTV. The mixing ratio of A and B is normally 1:1 for LSR, while for the HTV batches, 
the ratio usually 100:1.5 or higher. Curing temperature of silicone rubbers depends on 
the type, for LSR the most common condition is around 150 °C in minutes (5 to 15) 
under pressure and with or without post-curing for hours subsequently. Whereas in the 
case of RTV, the room temperature is sufficient for curing as name implied which takes 
usually within 1 hour. Moreover, the higher temperature may accelerate the curing pro-
cedure of RTV. 150 to 200 °C is applied on HTV to cure under pressure and the post-
curing is optional as well.  
4.1.1.1 Mechanical property of liquid silicone rubber 
The first impression of LSR is flexible, but in fact the hardness is varying from batch. 
From hardness Shore A 5 to 80, a broad range can be chosen. Along with the increasing 
hardness, the tensile strength is increasing as well, from 0.5 MPa to 11.0 MPa. However, 
the elongation at break is fluctuating, some batches keep both good strength and ductili-
ty. For example, the Silpuran
®
 6700 series have a medium Shore A hardness of 40 to 60, 
and the tensile strength is 8.5 MPa; meanwhile the elongation rate are keeping in 500% 
and higher. This strength is similar than that of low density polyethylene (LDPE), nylon 
4,6 and thermoplastic elastomer, and natural material such as ligaments in young human 
body
[53]
. 
Wide serving temperature window is an advantage of LSR in both cold and hot am-
bient. LSR can be used at 150 °C with almost no change in properties, and can with-
stand 200 °C for 10,000 hours or more. Some product batches are even tolerated more 
than 350°C which the most plastic and elastomer cannot bear. In cold environment, typ-
ical organic rubbers become brittle when it is less than -20 to -30 °C, while compared to 
-60 to -70 °C for LSR. Some batches are still serving at extreme low temperature of less 
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than -100 °C.
[54]
 These properties give LSR unique advantage not only in high tempera-
ture sterilization, but also in storage and operation application. For example, the cord 
blood stem cells are stored under -80 °C, therefore the liquid silicone rubber is a candi-
date for container of these cells.
[55]
 
Tear strength is the most important physical property for maxillofacial prosthetic 
material clinically, and the most common used material is PDMS.
[56]
 Thin margins of 
prosthesis is usually glued with medical adhesive to patient face and is peeled away at 
night or for cleaning. Therefore it is important that a material with a high resistance to 
tearing is used to construct theses prostheses to avoid the peeling damage. More gener-
ally, the tear strength of thin wall structure is critical when peeling or some sort of tear-
ing is applied on it potentially.
[56]
 The LSR offers high tear strength up to 41 N/mm, 
comparing to commercialized soft denture lining material which is around 10 N/mm.
[57]
 
4.1.1.2 Surface property of liquid silicone rubber 
LSR is hydrophobic material, and the low surface tension gives good release and repel-
lent properties. Moreover, LSR is capable to wet most surfaces which include itself.
[3]
 
For medical application, preventing microorganism contamination is a challenge for 
devices; even the sterilization is applied, the contamination can happen during operation 
or other activities. With the hydrophobic nature of LSR, the surface microorganism ab-
sorption is greatly reduced by slightly treatment.
[58]
 C. Price et al. found that after argon 
plasma treatment for 5 minutes and then immersed for 15 minutes in four separate silane 
solutions, the candida adhesion is greatly reduced.
[58]
 Zhenyu Li et al. have reported that 
ambient temperature slightly influences on the hydrophobicity in the region ranges from 
0 °C to 100 °C; while the surface energy clearly decreases with the increases of temper-
ature beyond 100 °C. And there is a trend that the higher temperature, the greater hy-
drophobicity of LSR.
[59]
 It is common that medical devices are exposing to saline for 
long time, and it might cause changes of material.
[60]
 J. J. Kennan et al. exposed LSR to 
saline under 37 °C and 100 °C for 45 hours, and they concluded that there is no indica-
tion of significant degradation and hydrolysis occurring as well as surface tension under 
aging conditions.
[60]
 
However, the high surface hydrophobicity of silicone rubber results in the adsorp-
tion of significant amounts of protein which constrains their use in biomedical applica-
tions. Especially in blood contacting applications, the mediate subsequent thrombotic 
and immunogenic effects with potentially catastrophic results are caused by non-
specific adsorption of plasma protein to an artificial surface.
[61]
 Therefore, it is neces-
sary to adjust the surface properties of LSR in order to enhance its biocompatibility. 
D. R. Bennett et al. claimed an invention that relates to a silicone substrate having 
heparin grafted to its surface. Heparin is a heterogeneous extended polymer that among 
the most frequently used therapeutic agents for thrombin regulation. The powder form 
heparin was introduced to the LSR surface before or after the ionizing radiation which 
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induces free radicals on the surface for grafting. The result of this invention shows a 
success reduction of non-specific protein absorption on LSR surface.
[62]
 The problem of 
this invention is to achieve a good graft outcome, it is recommended to dust the heparin 
powder into uncured or partially cured LSR then cure the product completely. Neverthe-
less, heparin might dysfunction after the heat vulcanization. 
Surface absorption feature of LSR can be modified via gas plasma treatment. The 
different gases are used in gas plasma treatment and the results are varying. R.L. Wil-
liams et al. have reported that hemocompatibility of LSR was dramatically affected by 
plasma treatment, both N2 and NH3 treatments causing a highly signiﬁcant reduction in 
factor XII activation caused by incubation with the surfaces, that of NH3 to a level al-
most indistinguishable from non-contacted platelet poor plasma (PPP).
[63]
 Treatment of 
LSR with both Ar and O2 induced a decrease in hemocompatibility, leading to shorter 
clotting times.
[63]
 The problem of this method is the high costs of plasma device. 
The other approach is achieved by simply introducing additive. Stadi et al. have re-
ported that incorporation of tungsten metal in powder form in LSR compositions in 
amounts as small as 0.5% by weight of the total composition inhibits blood clot for-
mation. There was neither deleterious effect of the tungsten in its environment in the 
bloodstream nor substantial degradation of the properties of the LSR as long as the 
amount of tungsten incorporation remains below about 33% by weight. An added ad-
vantage of the tungsten is X-ray opacity making the invasive device visible to X-rays.
[64]
 
This invention is applicable to any invasive device which can be formed from silicone 
rubber and to extracorporeal device designed for use in handling blood and parts of such 
devices which can be made from silicone rubber.
[64]
 
4.1.1.3 Biocompatibility of liquid silicone rubber 
P.V. Mohanan et al. have done a comprehensive biocompatibility tests as per the inter-
national protocol. This was no significant signs of toxicity shown in acute systemic 
studies throughout the period. No erythema and edema was observed at the intracutane-
ous injection sites of test sample at the end of study. The hemolysis induced by the LSR 
was well below the range. Histopathological evaluation of intramuscular implanted LSR 
showed an excellent biocompatibility. None of the animals have shown a rise of tem-
perature in pyrogen test. The safety and sterility tests resulted in satisfactory outcome as 
well.
[65]
 In conclusion, the biocompatibility of medical grade LSR is highly reliable.
[3]
 
Although LSR can be chemically degraded by substances capable of acting as de-
polymerization catalysts, their hydrophobic nature limits the extent of their contact with 
many aqueous solutions. Typically, the biologic milieu does not present a particularly 
hostile chemical environment for LSR.
[3]
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4.1.1.4 Sterilization resistance of liquid silicone rubber 
Due to high thermal stability and hydrophobicity of LSR, the autoclave and dry heat can 
be applied. The EtO and irradiation methods are investigated by Emilie Gautriaud et 
al.
[66]
, and three typical liquid silicone rubbers were examined. Peroxide cure high con-
sistency rubber (HCR) were hardened after both gamma and e-beam treatment; mean-
while, deterioration in mechanical properties (tensile strength, elongation, tear strength, 
etc.) were detected in all tested samples after irradiation sterilization and more pro-
nounced in the case of peroxide cure HCR. Therefore, it is not recommended the use 
peroxide cured liquid silicone rubber in any part or component that may be subjected to 
irradiation-based sterilization procedures. 
In contrast, EtO sterilization did not have a significant negative effect on the proper-
ties of commercialized liquid silicone rubbers; and it is even enhancing the tensile 
strength and tensile elongation of platinum catalyst LSR. For this reason, EtO is consid-
ered as the treatment to be the preferred method of sterilization for LSR-based medical 
components.
[66]
 
4.1.1.5 Chemical resistance of liquid silicone rubber 
The chemical resistance of LSR is varying from different batches and suppliers. In gen-
eral, LSR resists water, isopropyl alcohol, some acids, oxidizing chemicals, and ammo-
nia and can meet chemical resistance requirements in elevated temperatures and all me-
thyl silicones resist ozone. The concentrated acids, alkaline, and solvents should be 
avoided contacting with LSR. LSR can be formulated to enhance its chemical resistance 
to a given chemical solution. Flourosilicone rubbers (FSR) resist solvents and fuels, and 
are generally the best silicone rubbers to use in corrosive settings.
[67]
 
4.1.2 Processing of liquid silicone rubber 
The most commonly used methods of molding LSR are injection and compression 
molding. By the nature of liquid state of raw LSR and different thermal behavior, the 
LSR is processed with similar production rate of thermoplastics via utilizing slightly 
modified thermoplastics molding equipment.
[68]
 Thermoplastic resin is heated in the 
barrel and injected into a cold mold, while in contrast, LSR molding requires the liquid 
rubber to be kept cool in the barrel and injected into a heated mold. The tolerance, vent-
ing, and part ejection are aspects of tooling design that differ silicone from thermo-
plastic. The processing optimizing control is achieved by a similar way than thermo-
plastic, which temperature, pressure and time are essential adjustable parameters.
[67]
 
As suggested in surface property of LSR that wetting ability to other surfaces, parts 
fabricated from LSR can be easily bonded to metal, glass, ceramics, silicone-glass lami-
nates, or to LSR per se. Therefore, the coating procedure of LSR is simple without addi-
tional preparation and coating process.
[67]
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4.1.2.1 Injection molding of liquid silicone rubber 
Though similar to thermoplastic molding in many ways, LSR molding processing can 
be quite different. Figure 17 shows the molding cycle breakdown of LSR, cooling of 
thermoplastic is replaced by heated curing and the ejection of products are taking more 
time over that of thermoplastic molding.
[68]
 
 
Figure 17: Liquid silicone rubber molding cycle breakdown
[68]
 
The raw material components A and B, in most cases, are pumped from the origin 
container by pneumatic power. Then the two components are mixed under certain ratio, 
and colorant can be added at this stage. Before entering nuzzle, the LSR is screened to 
remove any gels, contaminations, or prematurely cured material that can develop in 
mixing device. Screen packs, consisting of several different mesh sizes, are retained in a 
steel housing with inlet and outlet ports. Like the barrel, nozzles are water cooled as 
well to prevent premature crosslinking during injection and dosing. The cooling chan-
nels are arranged so that they ensure the fluid path and cool nearer the nozzle tip, where 
LSR curing is most likely to occur. After cured in hot mold, demolding is particularly 
challenging due to the LSR’s relatively low viscosity. Ejector pin clearances may flash, 
thereof, demolding is often accomplished with other means such as brushes or ejector 
plates.
[68]
 
4.1.2.2 Liquid silicone rubber used as coating material 
A superior combination of bond and physical properties that LSR offers is an advantage 
that most organic rubbers cannot match. LSR can be bonded to any porous or non-
porous materials; the bond formed is highly durable and will readily withstand flex 
movement at high and low temperatures.
[67]
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Figure 18: Rotogravure coating
[69]
 
Typical methods for the application of LSR coating to substrate include: knife coat-
ing; dip/immersion coating; rotogravure coating (Figure 18); extrusion; spraying. With 
knife-coating methods, the outcome is influenced by blade type and angle as well as 
substrate; while rotogravure process ensures that the topcoat is delivered at a constant 
application rate and is not affected by substrate variability where facilitates higher line 
speeds.
[69]
 
4.2 Thermoplastics 
Thermoplastics are processed by applying elevated temperature, and the procedure is 
reversible. Therefore the recycle is an advantage of them compared to the thermosets. 
Based on performance, thermoplastics are categorized into commodity, engineering and 
high performance groups. The commodity plastics account for about 80% of plastics 
used for medical devices in applications like labware, tubing, containers, fixtures, and 
molded connectors.
[70]
 This classification is not the only one, yet there are many other 
different ways.
[43]
 Figure 19 shows the three groups in ascending fashion which the 
higher performance ones are in high hierarchies. 
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Figure 19: Classification of thermoplastics
[70][120][121][122][123]
 
It is noticeable that there are differences between amorphous and semi-crystalline 
plastics. Table 6 is a general comparison of them, and it is admitted that the high tech-
nology material can break the classification barrier. Amorphous plastics usually are 
more isotropic in mechanical properties than semi-crystalline ones which are affected 
by lattice orientation. In contrast, the chemical, thermal, and wear resistance of semi-
crystalline polymers are better. In addition, the transparency is highly depended on de-
gree of crystallinity.
[70]
 
Table 6: Amorphous and crystalline polymers comparison table
[70]
 
4.2.1 Property of thermoplastics 
Same as liquid silicone rubber and even more complicated, the properties of thermo-
plastics are varying by types, batches and suppliers. In this study, the properties dis-
cussed are based on the commercialized raw materials. Admittedly, the ever changing 
Commodity 
PVC, PS, 
COC 
 
PE, PP, Syndiotactic 
PS  
Engineering 
Acrylics, PC, 
Amorphous PET, ABS, 
SAN, PETG, PCTG, 
PCTA 
UHMWPE, Polyesters, 
Polyamides, Acetals, 
PET, PBT, PCT  
High 
performance 
Polysulfones, PEI 
Polyimide, PEEK, LCP,  
PPS,  Fluoropolymers,   
Property Amorphous Crystalline 
Optical Typically transparent, clear Typically translucent, opaque 
Melt viscosity High Low 
Melting point Broad softening point Sharp melting point 
Shrinkage Low High anisotropic, differential 
shrinkage 
Dimensional stability Good; consistent predictable 
shrinkage 
Fair 
Mold shrinkage Lower mold shrink; no post mold 
shrink 
Higher mold shrink; can have 
high post mold shrink 
Wear resistance Poor Good 
Chemical resistance Fair to poor Good 
Weld-ability Good Fair 
Heat resistance Lower Higher 
Performance 
Amorphous 
Semi- 
Crystalline 
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technology will make the boundary of commodity, engineering and high performance 
plastic more and more blurred. In addition, the properties of thermoplastics are greatly 
influenced by additives and fillers; in this study, the discussion is based on commercial-
ized pure polymers and ready-to-use compounded ones, such plasticized PVC. 
4.2.1.1 Mechanical property of thermoplastics 
The mechanical strength of commodity plastics is lower than engineering and high per-
formance thermoplastics. The ultra-high molecular weight polyethylene (UHMWPE) 
has the highest impact strength with good balance of tensile strength and elongation in 
polyethylene (PE) family. Among commodity plastics, cyclic olefin copolymer (COC) 
offers the highest rigidity and high light transmission rate. With similar light transmit-
tance of polymethyl methacrylate (PMMA), 92%, COC has much better heat resistance 
and only tenth of its moisture absorption.
[71]
  
Because of the structure and property diversity, polyurethanes (PU) are considered 
one of the most bio- and blood-compatible materials known today.
[72]
 However, based 
on the  rubber or hard plastic behavior in working temperature, PU are divided into plas-
tic-like PU and elastomer-like TPU.
[72]
 In this chapter, the plastic-like PU is discussed, 
while TPU is shown in next chapter. Properties like durability, fatigue resistance in ten-
sile/compression/shear, elastomer character propensity became attainable via utilization 
of diversified PUs.
[72]
  
Another important engineering plastic family is polyester, which includes homopol-
ymers: polyethylene terephthalate (PET), polybutylene terephthalate (PBT), polycyclo-
hexylenedimethylene terephthalate (PCT); polytrimethylene terephthalate (PTT) and 
copolymers: polyethylene terephthalate glycol (PETG), polycyclohexylenedimethylene 
terephthalate glycol (PCTG), polycyclohexylenedimethylene terephthalate acid 
(PCTA).
[73]
 PET is high stiffness plastic, whereas PBT is better in wrap resistance than 
PET and PCT has higher heat resistance than other polyester. PTT has good dimension-
al stability and excellent surface properties. The aim of polyester copolymers is to re-
duce the degree of crystallinity of polyester homopolymers. PETG is high stiffness plas-
tic with glass-like clarity; PCTG is clear and high impact resistance; and besides clarity, 
PCTA has higher thermal resistance and elongation than PETG.
[73] 
Polyamide is an old family of thermoplastics used for medical application; the 
commercialized materials are nylon 6, nylon 66, nylon 6/12, nylon 12 and nylon 4/6. 
They are light weight and robust material with balanced strength, and can be reinforced 
by glass fiber. However, the water absorption is a drawback of polyamide. The moisture 
content of polyamide can reach as high as 2.6% in nylon 6 and 2.8% in nylon 4/6. The 
existing of water can cause a decrease in strength and an increase in ductility. A re-
search group in BASF has tested the mechanical deteriorating of polyamide under dif-
ferent temperature at the presence of moisture, the greatest change was found at 23 °C 
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where 40% of its original tensile strength has lost, meanwhile, the total elongation has 
increased by 150%.
[74]
  
Overall, the mechanical strength of high performance plastics is not a superior com-
paring to engineering plastics. The advantage of high performance plastic in common is 
the high continuous use temperature as shown in Figure 20. Polysulfones (PSU) and 
polyetherimide (PEI) are strongest ones among amorphous plastic which combine high 
mechanical strength and 70% to 80% light transmittance.
[75]
 Polyether ether ketone 
(PEEK) is a typical stiff plastic with very high tensile strength and modulus.
[75]
 Fluoro-
polymers, such as polytetrafluoroethylene (PTFE), fluorinated ethylene propylene co-
polymer (FEP), and perfluoro alkoxy copolymer (PFA), are more ductile mechanically 
weaker than most engineering and high performance plastics. Nevertheless, the other 
advantages make them perform well for medical application.
[75]
 
In addition, the styrenics are polystyrene (PS) copolymers and blends with improved 
chemical resistance and heat resistance. And a better impact strength and toughness is 
achieved by introduction of rubber-like polybutadiene. The advantage of styrenics, such 
as styrene acrylonitrile (SAN) and methacrylate acrylonitrile butadiene styrene (MABS), 
is the high transparency along with high impact resistance.
[76] 
 
Figure 20: Continuous use temperatures of thermoplastics
[75]
 (Y-axis is temperature 
in °C) 
4.2.1.2 Surface property of thermoplastics 
The surface of a medical device is the place that contacting and interaction take place; 
therefore it is important to understand surface property of biomaterial. While the contact 
angle of water on a substrate is a good indicator of the relative hydrophobicity or hy-
drophobicity of a substrate, it is not good for the wettability of the substrate by other 
liquids.
[77]
 Critical surface tension γc is associated with the wettability or release proper-
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ties of a solid, which serves as a better predictor of the behavior of a solid with a range 
of liquids. When the surface tension is greater than 45 dynes/cm is called hydrophilic 
behavior, generally; hydrophobic behavior is observed with critical surface tension less 
than 35 dynes/cm.
 [77]
  As the surface tension decreases below 20 dynes/cm, the surface 
resist wetting by hydrocarbon oil and considered oleophobic as well as hydrophobic.
[77]
 
A general surface tension value for some plastics is given in Table 7, while the value is 
just a hint for a common view; the real value is varying with different compounding. 
Table 7: Surface tension of some plastics
[78][79][80][81][82]
 
 
It is notable that the water contact angle is not always increasing along with decreas-
ing of surface tension; and some fluctuation may happen in water contact results.
[78]
 The 
surface property of plastics is depending on other factors as well, such as porosity, func-
tional groups, surface weakness, and mold release agent residual after demolding.
[79]
 
The surface property of plastics can be changed or modified into desired manner by 
Abbreviation Polymer name Surface tension (Dynes/cm) 
PTFE Polytetrafluoroethylene 18-19 
FEP Fluorinated ethylene propylene copolymer 20 
 Acetal 21.2 to 44.5 
UHMWPE Ultrahigh molecular weight polyethylene 22.8 to 36.7 
PDMS Polydimethylsiloxane, silicone rubber  23 
 Natural rubber 24 
PVDF Polyvinylidene fluoride 25 
PVF Polyvinyl fluoride 28 
PP Polypropylene 29 to 31 
PE Polyethylene 30 to 33 
CTFE Polychlorotrifluoroethylene  31 
PBT Polybutylene Terephthalate 32 
PS Polystyrene  34 to 37 
PVC p Plasticized polyvinyl chloride 35 
 Polyacrylate (Acrylic film) 35 
ABS Acrylonitrile butadiene styrene 35 
 Nylon 12 36 
PVA Polyvinyl alcohol  37 
PU Polyurethane  38 
PPS Polyphenylene sulfide 38 
 Nylon 6 (polycaprolactam) 38 
PVC r Rigid PVC 39 
PMMA Polymethylmethacrylate 39 to 41 
PI Polyimide 40 
SAN Styrene acrylonitrile 40 
PET Polyethylene terephthalate 41 to 47 
PEO Polyethylene oxide 43 to 45 
 Nylon 6/6 45 to 46 
PC Polycarbonate 46 
PES Polyether sulfone 46 
PPO Polyphenylene oxide 47 
 Styrene butadiene rubber 48 
The value of each material is just one typical value among the whole material category which the name 
may present; the value is for reference only. 
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proper surface treatment. For instance, the surface adhesion can be enhanced by abra-
sion, corona discharge, plasma treatment or flame treatment.
[79]
 
4.2.1.3 Biocompatibility of thermoplastics 
Except polystyrene (PS), most of commodity thermoplastics can be found available bio-
compatible or hemocompatible grade batches from supplier. Although the raw material 
per se is biocompatible, the additives and processing may affect the bio-performance or 
show threats, as described in Chapter 2.2.2.1. For example, the plasticizer of PVC, 
which commonly is di(2-ethyl hexyl phthalate) (DEHP), is often suspected by different 
authority bodies such as FDA and ISO; and the DEHP contained material is forbidden is 
some areas which may involve children contacting. Another example is biocompatibil-
ity of polyethylene can be influenced by radiation sterilization caused surface oxida-
tion.
[83]
 
Engineering and high performance plastics, including many polymer families, are 
medical grade available in most cases; and can be improved in bio-/hemo-compatibility 
by surface modification.
[84]
 The thermoplastics are bio-stable unless it is denoted ‘bio-
degradable’. 
4.2.1.4 Sterilization and chemical resistance of thermoplastics 
The most commodity plastics can withstand EtO and irradiation sterilization under cer-
tain dosage and cycles. For some plastics, such as UHMWPE, a radiation induced sur-
face oxidation may happen; therefore, an inert gas atmosphere is required during pro-
cessing and even storage.
[85]
 The heat sterilization is not recommended to commodity 
plastics.
[83]
 The resistance of solvents like tetra hydro furan (THF) and methyl ethyl 
ketone (MEK) is poor for most commodity plastics.
[83]
 
Engineering plastics performs similarly in sterilization resistance than commodity 
ones. The polyamides are recommended to be sterilized by EtO only for reuse applica-
tion. High-heat polycarbonate is withstanding all common sterilization approaches that 
is an advantage in some applications.
[84]
 The chemical resistance of them is varying by 
different polymer families. Among these plastics, polyurethanes have the worst perfor-
mance in contacting with chemicals, generally.
[84]
 
The high performance plastics, except PTFE, can be sterilized by all sterilization 
methods. Moreover, they have excellent chemical resistance for most solvents and sa-
line.
[75]
 The Appendix 2 shows the sterilization and chemical resistance of some ther-
moplastics; and the level ‘good’ refers to long time and high dosage exposure stability, 
‘fair’ is short and medium time period and dosage exposure stability, while ‘poor’ 
means the method/solvent cannot be used. 
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4.2.2 Processing of thermoplastics 
Thermoplastics can be processed via conventional and new approaches into desired 
shape. However, the processing limits are often depended on the property of plastic it-
self. Such as UHWPE, PTFE, which are high viscosity polymers, are hard to be melt-
processed; in industry, they are usually processed by powder sintering instead. In addi-
tion, the improvement on the processing parameters may ease the process difficulty. For 
example, Shiraki et al. have invented a general way to process UHMWPE with injection 
molding machine by changed parameters. The flow rate and mold cavity opening size 
are increased based on normal PE processing to achieve better mold filling of 
UHMWPE molten flow.
[86]
 However, this invention is a challenge to mechanical prop-
erty of the nuzzle and mold. 
4.3 Thermoplastic elastomers 
Thermoplastic elastomers are a series of synthetic polymers that combine the properties 
of vulcanized rubber with the processing advantages of conventional thermoplastics. In 
other words, they allow the production of rubber-like articles using the fast processing 
equipment developed by the thermoplastics industry. Most of thermoplastic elastomers 
are phase-separated system under working temperature. The hard phase, usually are 
thermoplastics, contributes strength; and the soft rubber-like phase is achieved by elas-
tomer molecules.
[87]
 According to ISO 18064:2005 Thermoplastic elastomers – Nomen-
clature and abbreviated terms, a nomenclature system is established for thermoplastic 
elastomers based on the chemical composition or polymer involved.
[116]
 The term TPE 
refers generic name of thermoplastic elastomers; among TPEs, the categories such as 
TPU, TPS, TPV, TPO, TPA etc. are named by different composition and segments ar-
rangement.
[116]
 
TPU, known as one of the most intensive studied medical grade plastic
[72]
, gives 
myriad performance and property combination. As mentioned in previous chapter, TPU 
belongs to the great family of PU with elastomeric behavior. The advantage of TPU is 
the adjustability of properties by same intermediates and the biocompatibility is sus-
tained.
[72]
 For instance, the devices, which are utilizing different hardness/stiffness ma-
terials, can be designed and implemented from TPU with same intermediates but differ-
ent soft-segment and hard-segment ratio; and the biocompatibility is potentially same 
under this condition.
[72]
 
Some typical commercialized medical grade thermoplastic elastomer systems are 
polyurethane/elastomer block copolymers TPU (Monothane
TM
 from Dow
®
, Elastollan
®
 
from BASF and Versollan
TM
 from Polyone
TM
), polystyrene/(S-B-S+oil) blends TPS 
(Dynaflex
TM
 from Polyone
TM
, Thermolast
®
 from Kraiburg), polypropylene/(rubber + oil) 
dynamic vulcanizates TPV (Versalloy
TM
 from Polyone
TM
), polyethylene/(polyolefin 
rubber) block copolymers TPO (Dynalloy
TM
 from Polyone
TM
, Versify
TM
 from Dow
®
), 
polyester/elastomer block copolymers TPE (Hytrel
®
 from DuPont
®
) and polyam-
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ide/elastomer block copolymers TPA (Vestamid
®
 from Evonik). Some other suppliers 
are keeping their formulation undisclosed, such as Medalist
®
 from Teknorapex. 
4.3.1 Properties of thermoplastic elastomers 
The properties of TPEs are depended on the hard and soft phase structure and composi-
tion. Over conventional thermosets, TPEs are: 1) able to be processed more efficient 
and lower in cost; 2) there is little or no compounding which TPEs is supplied fully 
formulated and ready for fabrication; 3) the TPEs scrap can be reused as a regrind fre-
quently producing materials have the same properties as the virgin material. However, 
there are some disadvantages of TPEs comparing to thermosets: 1) The number of TPEs 
softer than 50 Shore A is rather limited; 2) The drying prior to processing is common in 
manufacture of TPEs, whereas this step is almost never used for conventional thermo-
sets.
[87]
 
4.3.1.1 Mechanical property of thermoplastic elastomers 
The mechanical property of TPEs is in between the liquid silicone rubber and engineer-
ing thermoplastics. The tensile strength of TPEs can be much higher than that of liquid 
silicone rubber, up to some 50 MPa, and can be as soft as less than 5 MPa depends on 
types.
[76]
 Large elongation at break and low flexural modulus make them a rubber-like 
state. Due to molting ability of hard phase, the continuous use temperature is commonly 
no higher than normal plastics.
[88]
 Due to elevated melting temperature, the TPE parts is 
limited serve accurately below their melting point.
[87]
 
4.3.1.2 Surface property of thermoplastic elastomers 
It is known that the best combinations of elastomer and thermoplastic for TPEs are 
those in which the surface energy of the two components are matched.
[89]
 Therefore the 
surface energy of TPEs can be predicted by thermoplastic component which listed in 
previous chapter. 
4.3.1.3 Biocompatibility of thermoplastic elastomers 
The biocompatibility of TPEs is one highly promising advantage compare to the ther-
mosets in medical area. Heavy metals (e.g. tin) and halogens (e.g. chlorine and bromine) 
that used in thermoset rubber which can leach into medications and cause disposal prob-
lems, are undesirable according to safety concerns. TPEs alter the situation by providing 
rubber-like behavior and simple compounding simultaneously.
[90]
 In bio-inertness and 
low level of extractables and leachables property of medical grade TPEs are keeping 
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increasing in medical plastic market.
[90]
 The TPEs are bio-stable unless it is denoted 
‘biodegradable’. 
4.3.1.4 Sterilization and chemical resistance of thermoplastic elasto-
mers 
Due to thermal characteristic of TPEs, EtO and irradiation are recommended. Generally, 
THF, MEK, and dichloromethane, these solvents are harmful to TPEs.
[76]
 The steriliza-
tion resistances of specific commercialized TPEs, which are used for medical applica-
tion, are shown in Table 8. However, the actual part to the intended sterilization regime 
as factors such as wall thickness, dosage, number of cycles, can affect the results.
[92]
 
Table 8: Sterilization resistance for some TPEs batches.
[91][92][93][94][95]
 
4.3.2 Processing of thermoplastic elastomers 
Because of the large number of types of TPEs, specific processing methods and 
conditions used for individual TPEs are provided by suppliers. It is noticeable that if the 
material is moved form a relatively cool store to a warm and humid environment in the 
processing plant, the drying needs to be applied.
[96]
 Some TPEs tend to absorb moisture 
and these, of course, require thorough drying.
[96]
 The TPEs are processed via normal 
thermoplastic fabrication method, and the production rate is similar by same approach, 
such as injection and extrusion.
[96]
 
  
Material category Trade name EtO Autoclave Dry 
heat 
Gamma E-beam 
Polyurethane/elastomer 
block copolymers 
Elastollan® Good Poor Poor Fair - 
Polyester/elastomer block 
copolymers 
Hytrel® Good Fair Fair Good Good 
- Medalist® - Fair Fair Good - 
Polystyrene/(S-B-S+oil) 
blends 
Thermolast® Good Poor to Fair - Good - 
Dynaflex
TM
 Good Poor - Good Good 
Polyamide/elastomer block 
copolymers 
Vestamid® - Fair - - - 
- Versaflex® Good Poor to Fair - Good Good 
Poor: Not suitable for most applications 
Fair: Suitable for some applications 
Good: Suitable for most applications 
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5. MEDICAL APPLICATIONS 
The polymeric material based devices exist in every aspect of medical area, from simple 
container to sophisticated NMR coil hosing, and from extracorporeal assistance applica-
tion to invasive implants. This ever changing field makes a great opportunity and chal-
lenge for the manufacturers who want to step into medical device industry. The possible 
applications of medical grade polymeric material are depended on the mechanical prop-
erty, biocompatibility and cost efficiency. According to Chapter 2.4: Regulatory issues, 
the medical devices can be categorized by ISO 10993, as shown in Table 9. 
However, most of the examples listed in Table 9, are integrated systems which as-
sembled by various functional components. In order to simplify the production issues of 
complex configuration, the medical devices/components are discussed in this study by 
following three application groups: extracorporeal storage application; extracorporeal 
non-storage application; overmolding (a technical application). 
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Table 9: ISO 10993 device categories
[92]
 
Device catego-
ries 
Body contact Examples 
Surface 
Device 
Skin  Electrodes 
 External prostheses 
 Fixation tapes 
 Compression bandages 
 Monitors of various types 
Mucous Membrane  Contact lenses, urinary catheters 
 Intravaginal and intraintestinal devices (stomach tubes, 
sigmoidoscopes, colonoscopes, gastroscopes) 
 Endotracheal tubes 
 Bronchoscopes 
 Dental prostheses 
 Orthodontic devices  
 Intrauterine device (IUDs) 
Breached or Com-
promised Surfaces 
 Ulcer, burn and granulation tissue dressings or healing 
devices 
 Occlusive patches 
External 
Communication 
Devices 
Blood Path Indirect  Solution administration sets 
 Extension sets 
 Transfer sets 
 Blood administration sets 
Tissue/Bone/Dentin 
Communicating 
 Laparoscopes 
 Arthroscopes 
 Draining systems 
 Dental cements 
 Dental filling materials 
 Skin staples 
Circulation  Intravascular catheters,  
 Temporary pacemaker electrodes 
 Oxygenators 
 Extracorporeal oxygenator tubing and accessories 
 Dialysers, dialysis tubing and accessories 
 Hemoadsorbents and immunoadsorbents 
Implant Devices Tissue/Bone Implant 
Devices 
 Orthopedic pins, plates 
 Replacement joints 
 Bone prostheses, cement and intraosseous devices 
 Pacemakers 
 Drug supply devices 
 Neuromuscular sensors and simulators 
 Replacement tendons 
 Breast implants 
 Artificial larynxes 
 Subperiosteal implants  
 Ligation clipS 
Blood  Pacemaker electrodes  
 Artificial arteriovenous fistulae 
 Heart valves 
 Vascular grafts 
 Internal drug delivery catheters 
 Ventricular assist devices 
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5.1 Extracorporeal storage application 
The extracorporeal storage application refers to the devices which storing, channeling, 
or mixing of liquid or gas.
[46]
 The liquid can be water, saline, solvent, blood, lymph, etc. 
according to intended use of device; and the gas is air, CO2, inert gases, etc. As per clas-
sification, these devices are normally Class I or Class IIa.
[46]
 
5.1.1 Liquid or gas channeling devices 
The liquid or gas channeling devices have structures that let liquid or gas go through by 
certain direction and controlled speed, and sometimes split or mix the liquid or gas. Re-
quirements for these devices are drawn from the functioning environment and type of 
liquid or gas whom contact with.
[46]
 
Tubing is the most common channeling structure, along with several accessories 
such as tube fittings, Y-sites, connectors, stoppers and closures, valves, filters, etc. Fig-
ure 21 is an example of liquid infusion set which includes tubing, fitting, stopper, flow 
control unit and clip, and drip chamber. It is clear that different parts of this set are 
made separately and assembled. The material selection for this example is depend on 
each part requirements. In general, the tubing material should meet: 
1) Clarity 
2) Colorability 
3) Flexibility 
4) Kink resistance 
5) Wall thickness variety 
6) Chemical resistance 
7) Low surface absorption 
8) Sterilization and re-sterilization resistance (reused) 
9) Lubricity 
And the fitting, filter and drip chamber should have good dimensional stability in 
addition. While the flow control unit and clip are not contacting the fluid or gas directly, 
therefore the surface property is not crucial. The mechanical toughness which allows 
repeated operation is needed instead. According to these requirements, the material se-
lection can be done by optimizing the performance and cost.
[75][76][83][84]
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Figure 21: Liquid infusion set
[97] 
Among different medical tubing, ranging from diameters and properties, multi-
lumen tubing is a special category which may have a promised future potential. The 
purpose of a multi-lumen tube is miniaturize different function sections within smallest 
diameter, and originally, in order to promote less invasive procedures.
[98]
 It is used in 
catheter design firstly, and expanded to fluid management, air lines, cooling lines, etc.
[99]
 
Due to the complex structure, the tolerance is a key factor for material selection and 
fabrication. Multi-lumen tubing can be fabricated via two approaches: extrusion and 
assembling, examples are given in Figure 22. The ‘building up’ of multi-lumen structure 
shown in Figure 22 (b) incorporates diverse materials that not chemical compatible, 
such as braid/coil reinforcement, PTFE liners, etc.
[98]
 
 
Figure 22: Left (a), 9 lumen co-extruded bump tubing; Right (b), Complex catheter 
assembly
[98]
 
When the channeled liquid is body fluid and the full function of this liquid should be 
preserved, the device-liquid interface interaction is highly forbidden. The undesired 
composition change of channeled fluid is not allowed; therefore the surface property 
dominates material selection for such applications.
[46]
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5.1.2 Liquid or gas storing devices 
Liquid or gas storing devices act as barrier between contained liquid or gas and storing 
environment. The seal-ability is sometimes needed or can be complemented by a lid. 
The aim of such devices is keeping the functionality of stored substrate under a certain 
time. The requirements for material selection are as following, in general: 
1) High clarity 
2) Shatter resistance 
3) Low extractable and leachable 
4) Low surface absorption 
5) Water vapor barrier 
6) Chemical and (re-) sterilization resistance 
7) Dimensional stability 
8) Light weight[75][76][83][84] 
One example of function container is suction jar, which is usually made from poly-
sulfone or polycarbonate. As shown in Figure 23, a flexible bag, where the fluids are 
collected, is a separate part adapted to the vessel of the suction jar; and the vacuum is 
applied between the jar and flexible bag. The idea of this invention is to drain fluids 
from a cavity, particularly in surgery. After operation, the flexible bag is discarded and 
the jar is sterilized.
[100]
 In this kind of device, the parts are assembled, and seal-ability is 
key factor affecting the performance. 
 
Figure 23: Suction jar
[100] 
Cuvettes, which are used for spectrophotometric, are a good example of high preci-
sion container. The high material purity, critical tolerance, high light transmittance are 
required. Cuvettes are usually made from PMMA, while in the case that heating is ap-
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plied, COC is a good candidate.
[71]
 The design of cuvettes should be fitted into commer-
cial photometers without need for adapters
[101]
, example is given in figure 24. 
 
Figure 24: Cuvettes
[101]
 
The plastic liquid/gas storing devices are sometimes designed to be disposable. 
Therefore, the packaged products should be sterilized by irradiation and ready-to-use.
[28]
 
5.1.3 Liquid or gas administrating devices 
This group of devices can transfer, modify the liquid or gas flow into certain targeted 
place, the typical examples are syringe and inhaler. The requirements for these devices 
are: 
1) Clarity (not necessary for inhalers) 
2) Impact resistance and toughness 
3) Shatter resistance 
4) Dimensional stability 
5) Chemical and (re-) sterilization resistance 
6) Low extractable and leachable 
7) Burst strength[75][76][83][84] 
In addition, the parts precision, abrasion, wear resistance and low coefficient are 
demanded for inhaler material.
[102]
 In Europe, dry powder inhalers (DPIs) are a widely 
accepted inhaled delivery dosage forms by a large number of patients for the delivery of 
medications to treat asthma and chronic obstructive pulmonary diseases.
[102]
 As a highly 
efficient system for pulmonary drug delivery, DPIs are also complicated systems which 
rely on design, powder formulation, and airflow generated by the patient.
[102]
 An com-
mercial example is Diskus
®
, a multi-dose device. It contains 60 doses in a foul-foil alu-
minum strip that is indexed, and the does blister is only opened just prior to patient in-
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spiration, as shown in Figure 25.
[102] 
Admittedly, the part design and manufacture re-
quire high precision level. 
 
 
Figure 25: Diskus® dry powder inhaler
[103]
 
Syringe is a drug and vaccine administrative tool used for over 100 years, and is still 
improving. Today, prefilled syringes provide excellent convenience for emergency and 
self-administrated medication because of their ease of use and immediate availabil-
ity.
[104]
 For this purpose, the syringe is functioning for both storing and administrating; 
therefore, the material selection should take these issues into consideration. For the sake 
of convenience, color-code is applied as shown in Figure 26. 
 
Figure 26: UltraSafe
®
 syringe color-coded needle guards (left); the UltraSafe
®
 Passive 
Delivery System (right)
[104]
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5.2 Extracorporeal non-storage application 
This group refers to the application that functioning as operation tool, protector, struc-
ture, etc., rather than channeling, storing, administrating liquid or gas. As per classifica-
tion, these devices are normally Class I and Class IIa.
[46]
 
5.2.1 Surgical instrument 
The low cost, light weight, colorable, clear, and disposable of plastic are driven force of 
it to replace metal made surgical instruments, such as scalpel handle, tweezers, clamps, 
dental tools, trays, forceps, etc. As shown in Figure 27, an ankle clamp designed by 
John Grecco of Stryker Orthopaedics which was used to be metal made in the right side.
 
Now the yoke and flippers are made from polysulfone which is capable with multiple 
steam autoclaves and tough enough during operation.
[28]
 
 
Figure 27: Plastic ankle clamp: a replacement of metal component
[28]
 
5.2.2 Protective devices 
The medical protective device is used for keeping harmful particles, vapor, and micro-
organism away from operating personnel and patients. Respirator is a common protec-
tive device used in many industries to avoid respiration system contamination. The de-
sign of respirator is flexible to meet different barrier levels and reusable or disposable. 
A typical respirator design is shown in Figure 28, which contains soft and hard molded 
parts. And a diaphragm attachment is shown in Figure 29 that is functioning as filter 
accessory to the mask in Figure 28. 
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Figure 28: Respirator: face mask
[105]
 
 
Figure 29: Respirator: diaphragm, a breakdown drawing
[105]
 
The wearing conformability and seal-ability are key issues to be considered of respi-
rator design and material selection. Grace Lu-Yao et al. have reported that a large per-
centage of participants in their test were unwilling to wear the respirator ensembles for 
the entire 8-hour work shift, even with interposed break periods
[106]
; therefore, there is 
still space to improve on this object. 
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5.2.3 Medical instrumentation component 
As shown in Figure 30, variety of medical instrumentation parts can be made from plas-
tic, due to the light weight and other advantages over metal and ceramic. 
 
Figure 30: Plastic medical instrument parts 
In some advanced applications, the electrical insulation, radiation opaqueness or 
transmittance, thermal stability, surface absorption, and chemical resistance are required. 
The flexibility and modifiability of plastics have offered a broad range for designer and 
manufacturer.
[43]
 An example is given in Figure 31, which is MRI receiver coil configu-
ration from Siemens. The mechanical stability, easy to clean, electrical insulation and 
radiation transmittance, and chemical resistance are key factors to design and select 
material for this device. 
 
Figure 31: 32-channel head coil for MRI, Siemens.
[107]
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The Emerge
TM
 PC/PET9500CR advanced resin from Styron, Berwyn, PA, is a plas-
tic material designed to provide chemical and ignition resistance, durability, processing 
characteristics, and aesthetic appeal. It also offers resistance to aggressive chemicals, 
including surface disinfectants and cleaners commonly used in medical environments, 
which can attack plastic surfaces and cause crazing, cracking, or product failure.
[108]
 It is 
particular one among the commercialized plastics that meet the requirement for medical 
instrumentation and ready-to-process for manufacturer without extra compounding.  
5.3 Overmolding 
Overmolding, an injection process also known as two shot molding, has drastically 
changed the aesthetics, design, and functionality of consumer products over the last 
decade. Its potential benefits for medical application is raised by the requirements of 
user friendly texture, ergonomics, multi-color aesthetics, brand identification, and prop-
erty modification. Plastics are used in overmolding to offer functionality addition such 
as noise and vibration dampening, waterproofing, and shock absorption in order to in-
crease products’ value. Co-injection, two shot, and sandwich molding are typical meth-
ods applied for overmolding technique.
[110]
 
The basic premise of overmolding is to take economical advantage of two or more 
materials with uniquely different properties by incorporating them into a single molded 
component. A success overmolding is achieved by stable material bonding. There are 
three basic bonding fundamental, and they can work either individually or in a combina-
tion: 1) molecular adhesion; 2) mechanical design techniques; 3) mechanical interlocks. 
The molecular adhesion is determined by overmolding material surface wetting and 
reaction, or favored by bonding agents. Liquid silicone rubber can wet a broad range of 
metal, thermoplastic, or itself; however, the curing condition of silicone rubber, which 
usually over 100 °C, can cause heat distortion to thermoplastic. The thermoplastic and 
thermoplastic elastomer usually wet the substrate with similar surface tension. The ma-
terial bonding instruction is sometimes provided by supplier, for instance, the GLS 
group suggests their thermoplastic elastomer Versaflex
®
 and Versollan
TM
 are able to 
bond to PC, ABS, nylon, coployester, PS, acetal and (all above) their alloys or 
blends.
[109]
 Nevertheless, it is not capable for some material suppliers. 
The mechanical design techniques are achieved by geometric conjunction which 
varies among different products. The most common way to get solid bonding physically 
is mechanical interlock. Via this approach, shown in Figure 32, the sophisticated mate-
rial selection procedure or surface integrative design might be eased. 
 56 
 
Figure 32: Three types of successful mechanical interlocks
[109]
 
An advantage to use plastic overmold to metal is ergonomic pursuit and cost effi-
ciency. In some cases, a part with complex geometry to fit the contours of the human 
body is easier to process by molding plastic than metal machining. Moreover, the soft 
touch of plastic may increase the ergonomic concern. An example is shown in Figure 33, 
these surgical instrument handles were overmolded by thermoplastic elastomer with soft 
touch and non-slippery texture.
[110]
 
 
Figure 33: Overmolding surgical instruments handle set
[110]
 
Depending on application, the biocompatibility, chemical and sterilization resistance 
should be taken into consideration as well. The other requirements, which are important 
for fragile devices, are shock absorption, and waterproofing to ensure the devices work 
well in emergency and harsh situation. Automated external defibrillator (AED) unit in 
Figure 34 is overmolded around the frame and corner. The test protocol for this unit 
included passing a 1.5-m drop test, a cyclic loading test, and a water ingress test. The 
results has shown an optimal performance-property profile for this overmolded AED 
unit.
[110]
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Figure 34: Overmolded AED unit
[110]
 
In addition, this is a good example of plastic-on-plastic overmolding as well. The 
black material is thermoplastic elastomer with soft touch, good seal-ability; and the 
green substrate is rigid, impact resistant resin. The combination of these two plastic re-
sulted in excellent engineering performance. 
5.4 Case study 
As mentioned previously, some medical devices are multi-component assembled con-
figurations. The functionality is achieved by exquisitely designed elements. Table 10 
shows some commercialized plastic materials and their possible applications in order to 
illustrate the broad range of options in this industry. The sequencing is based on approx-
imate hardness of each plastic family; the representation of each hardness level in real 
life is given in Figure 35. Subsequently, two cases are given to make a direct impression 
of real practice. 
 
Figure 35: Shore hardness scale
[111]
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Table 10: Commercialized medical grade plastic material and application (Ascending 
order of hardness)
 [75][76][83][84]
 
Material 
category 
Trade name and supplier Hardness Possible application 
Silicone rub-
ber 
 Silpuran® and Elastosil® 
(Wacker, Germany),  
 Silastic® (Dow Corning, 
USA) 
Shore 00 15 
to Shore A 
70 
 Medical tubing and catheters 
 Gaskets 
 Membrane 
 Seals 
 Valves 
 Balloons 
 Mammary prosthesis 
 Orthopedics 
Thermoplastic 
elastomers 
See chapter 4.3 Shore A 5 to 
shore D 75 
 Medical tubing and catheters 
 Heat shrinkage tubing 
 Stoppers and closures 
 Fluid delivery connectors and 
clips 
 Films 
 Collecting bags 
 Eye and nasal drop bottles 
 Gloves 
 Gel filled bladder, neck pack 
 Overmoding 
PVC Hy-Vin® and Evicom
TM
 (INEOS, 
France) 
Shore A 50 
to 91 
 Medical tubing 
 Catheters 
 Bottles 
 Drip chambers 
 Packaging 
 Gloves 
 Masks 
 Blood contacting containers 
COC TOPAS® (TOPAS, Germany) Shore A 89  Packaging 
 Lab-on-a-chip disc 
 Prefilled syringes and containers 
 Labware 
 Cuvettes 
UHMWPE HI-ZEX MILLION® (Mitsui 
Chemicals, Japan) 
Shore D 30 
to 50 
 Artificial limb material 
 Acetabular joint 
 Sutures 
 Heart valves 
LDPE  Eletx®LDPE (INEOS, 
France) 
 Riblene® (Eni Versalis, 
Italy) 
Shore D 55  Medical tubing 
 Caps for luers and bottles 
 Packaging 
 IV fluid bottles 
 Single does ampoules 
PS  Styrolution® PS (Stryrolu-
tion, Germany) 
Shore D 58  Labware 
 Sterilization trays 
 IV fluid bottles 
 Single does ampoules 
PP Eletx®PP (INEOS, France) Shore D 55 
to 65 
 Drape and gowns 
 Packaging 
 Pouch 
 Syringes 
HDPE  Eletx® HDPE (INEOS, 
France) 
 Eraclene® (Eni Versalis, 
Shore D 68  Slide clamp 
 Filters 
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Italy) 
PMMA Plexiglas® and Altuglas® Luc-
tor
TM 
Medical grade
 
(Plexiglas, 
Germany) 
Rockwell M 
21 to 84 
 Labware 
 Cuvettes 
PC  WONDERLITE®PC 
(CHIMEI, Taiwan) 
 Durolon®PC (Unigel, 
Brazil) 
Rockwell M 
75 to 90 
 Intravenous IV components 
 Needle-free injection system 
 Heart valves 
 Ventricular assist devices 
 Connectors 
 Dialyzer components 
 Device housing 
PU Texin® and Desmopan® 
(Bayer, Germany) 
Shore A 85 
to D 70 
 Thin-walled flexible tubing 
 Catheters 
 Connectors, luers and stopcocks 
 Films and fabric coatings 
 Component housings 
 Soft-touch grips 
 Ventricular assist devices 
 Pacemaker leads 
PTFE Teflon® (Dupont, USA) Shore D 50 
to 59 
 Multi-lumen tubing 
 Heat shrinkable tubing 
 Guiding catheters 
 Vascular graft 
 Low surface tension applications 
PSU Ultrason® (BASF, Germany) Shore D 80  Flow control devices 
 Dialysis membrane 
 Surgical instruments 
 Suction jars 
PPS Ryton® (Chevron Phillips, USA) Shore D 85  Surgical instruments 
 Valves 
 Filters 
PBT Crastin® (Dupont, USA) Shore D 85  Miniature scalpel blade holders 
 Syringe pump component 
PEEK Victrex® (Victrex, UK) Shore D 87  Heat shrinkable tubing 
 Valves 
 Tri-leaflet heart valve 
 Spinal cages 
 Pins, screws and plates 
 Dental implants 
PET Rynite® (Dupont, USA) Shore D 95  Heat shrinkable tubing 
 Labware 
 Packaging 
 Blood separation cassette 
 Angiographic syringe 
ABS Teluran® (BASF, Germany) Shore D 100  Surgical instruments 
 Device components 
 Device housing 
 Inhaler components 
 Intravenous IV components 
PA Zytel® PA (Dupont, USA) Rockwell R 
70 to 121 
 Medical tubing 
 Catheters 
 Sutures 
 Stopcocks 
 Device housing 
 Packaging 
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5.4.1 Case I: Housing design for a new RF breast coil concept for use in 
MRI applications[112] 
Based on new Aghogho Obi’s dual channel RF breast coil concept, the author has been 
asked to carry out a housing design witch address ergonomics, weight, size, structural 
and regulatory issues by InsightMRI (an American MRI corporation). According to its 
application, it is a Class I device. 
 Ergonomic: The patient should be comfortable during the entire screening pro-
cess where MRI scans take longer time than other mechanical imaging methods. 
The patient’s movement caused artifacts and distortions should be eliminated. 
 Weight and size: Due to the handle of device, lightweight is preferred. Mean-
while, the size should keep as low profile as possible to increase the amount of 
free space on the magnet’s bore. 
 Structure integrity: This device is bearing different loading. 
 Regulations: This device is able to perform within the dictated by both regulato-
ry agencies (FDA, ISO, etc.) and the vendors (such as MRI system supplier: 
Siemens, Philips or GE). The regulations can be for extremely minute details 
(wall thickness around heat producing electrical elements) or for more general 
criteria (melting point of the material used). 
The final design is shown in Figure 36. 
 
Figure 36: Breast MRI coil housing design
[112]
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Table 11: List of materials
[112]
 
The materials used in this design are shown in Table 11. For the aesthetic purpose, 
an off-white pigment is incorporated into the material or painted after molding. Any of 
the externally exposed surfaces of machined parts are also painted. 
5.4.2 Case II: CentriMag® Right ventricular assist system component: 
blood pump[113] 
The CentriMag
®
 blood pump, shown in Figure 37, is an extracorporeal circulatory sup-
port device providing hemodynamic stabilization in patients in need of cardiopulmonary 
support. It is designed by Thoratec
®
 Corporation, USA, and made from medical grade 
polycarbonate.
[113]
 CentriMag
®
 is CE-Marked in Europe for use up to 30 days to pro-
vide hemodynamic support for patients as a bridge to recovery, transplant, or a short-
term ventricular assist device (VAD). CentriMag
®
 is also CE-Marked in Europe for use 
up to 30 days as a component of an extracorporeal membrane oxygenation (ECMO) 
circuit to provide support to patients in need of cardiac and/or respiratory assist. Ac-
cording to its application, it is a Class IIa device. 
 
Figure 37: CentriMag
®
 blood pump
[113]
 
The quality and functionality of CentriMag
®
 is approved according to FDA and ISO 
standards which cover the biocompatibility, sterilization validation, hemolysis testing, 
shelf life studies, and shipping/transportation tests. The biocompatibility tests included:  
Part Material Description 
Main Housing Parts Ultem
TM
 2300:
 
30% glass-reinforced polyi-
mide thermoplastic flame retardant resin 
Garolite G-10: Reinforced glass-cloth flame 
retardant composite epoxy resin 
RapidCast® RC-79D: Flame retardant polyure-
thane 
Leg (Outer) Ultem 2300  
Leg (Inner) G-10 
Housing (Top Half) RC-79D 
Housing (Bottom Half) RC-79D 
Covers 
Top Half-Top Cover RC-79D 
Top Half-Bottom Cover Nylon 
Bottom Half-Bottom Cover Nylon 
Rail Mount Ultem 2300 
Fastening Features Brass or Nylon 
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cytotoxicity, sensitization, intracutaneous irritation, systemic toxicity, genotoxicity, he-
mocompatibility and sub-chronic toxicity. The recommended sterilization approach is 
EtO method. In addition, the packaging integrity of this device ensures the functionality 
under certain shelf time and transportation.
[114]
 F.D. Robertis et al. have revealed the 
efficiency of CentriMag
®
 as well as a low-cost device based on clinical test.
[115]
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6. CONCLUSION 
In order to provide a comprehensive production procedure of polymeric medical devices, 
thorough discussion of technical details is made in this study. Furthermore, the require-
ments of regulatory issues are emphasized at each processing stage. It is clear that a 
valid medical device production is achieved when not only the technical aspect is ful-
filled, but also the regulatory demand is complied. Therefore a feasible analysis is nec-
essarily carried out prior to real production. Following the production synopsis given in 
this study, a project analysis can be made via a logical approach. 
Inspired by the sponsor of this study, the polymeric materials (liquid silicone rubber, 
thermoplastics, and thermoplastic elastomers) are widely discussed and compared based 
on mechanical property, biocompatibility, surface property, sterilization and chemical 
resistance, etc. Subsequently, possible applications of these materials are given in a ma-
terial-application manner. Such information can ease the initial selection procedure of a 
manufacturer.  Finally, two case studies are given to illustrate the real practice of previ-
ous discussion. 
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APPENDIX 1 
Appendix 1.1 
Decision tree for sterilization choices for aqueous products
[18]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Can the product be sterilized by moist 
heat at 121℃ for 15 minutes 
YES NO 
Can the product be sterilized by moist heat with 
Fo≥8minutes achieving SAL of ≤10-6 
Use autoclaving at 
121℃ for 15 minutes 
NO 
Can the formulation be filtered 
through a microbial retentive filter 
YES 
Use moist heat with Fo
≥8minutes 
NO 
Use pre-sterilized individual 
components and aseptic 
compounding and filling 
Use a combination of 
aseptic filtration and 
aseptic processing 
YES 
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Appendix 1.2 
Decision tree for sterilization choices for non-aqueous liquid, semi-solid or dry solid or 
dry powder products
[18]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Can the product be sterilized by dry 
heat at 160℃ for 120 minutes 
NO YES 
Can the product be sterilized by dry heat with an 
alternative combination of time and temperature 
to the standard cycle achieving an SAL of ≤10-6 
NO YES 
Use sterilization at 
160℃ for 120 minutes 
 
Can the product be sterilized by a method dif-
ferent from dry heat e.g. ionizing radiation 
with an absorbed minimum does of ≥25 KGy 
Use dry heat alternative combina-
tion of time and temperature to 
standard cycle achieving an SAL of 
≤10-6 
NO YES 
Can the formulation be sterilized using a validated 
lower irradiation dose (ref. ISO 11137) 
Use sterilization with an absorbed 
minimum does of ≥25 KGy 
Can the formulation be filtered through a 
microbial retentive filter 
NO YES 
Use sterilization by vali-
dated irradiation dose 
NO YES 
Use pre-sterilized individual components 
and aseptic compounding and filling 
Use filtration and aseptic 
processing 
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APPENDIX 2 
Appendix 2.1 
Sterilization resistance of some thermoplastics
[75][76][83][84]
 
 Steam Dry heat Ethylene 
oxide 
E-Beam Gamma 
radiation 
Gamma 
tolerance 
level (KGy) 
PVC-U Poor Poor Good Fair Fair 100 
PVC-P Fair Fair Good Good Good - 
LLDPE Poor Poor Good Good Good 1000 
LDPE Poor Poor Good Good Good 1000 
HDPE Poor Poor Good Good Good 1000 
UHMWPE Poor Poor Good Good Good 1000 
PP Good Fair Good Fair Fair 25-60 
COC Fair Fair Good Good Good - 
PS Poor Poor Good Good Good 10000 
PMMA Poor Poor Good Good Good 100 
PC Fair Fair Good Good Good 1000 
PU Poor Poor Good Good Good 10000 
Acetal Good Good Good Poor Poor 5 
PET Poor Poor Good Good Good 1000 
PBT Fair Fair Good Good Good - 
PCT Poor Poor Good Good Good - 
PETG Poor Poor Good Good Good 1000 
PCTG Poor Poor Good Good Good - 
PCTA Poor Poor Good Good Good - 
PA 6 Fair Fair Good Fair Fair 50 
PA 66 Fair Fair Good Fair Fair - 
PA 6, 12 Fair Fair Good Fair Fair - 
PA 12 Fair Fair Good Fair Fair - 
Nylon 4,6 Fair Fair Good Fair Fair - 
PSU Good Good Good Good Good 10000 
PES Good Good Good Good Good - 
PPSU Good Good Good Good Good - 
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PEI Fair Fair Good Good Good - 
PAI Fair Fair Good Good Good 10000 
PPS Good Good Good Good Good 1000 
PEEK Good Good Good Good Good - 
PEKK Good Good Good Good Good - 
PEKEKK Good Good Good Good Good - 
LCP 1 Good Good Good Good Good - 
LCP 2 Good Good Good Good Good - 
PTFE Fair Fair Good Poor Poor 5 
PFA Good Good Good Good Good - 
FEP Good Good Good Fair Fair 50 
PVDF Good Good Good Good Good 1000 
PCTFE Good Good Good Good Good - 
ETFE Good Good Good Good Good 1000 
ECTFE Good Good Good Good Good 200 
ABS Poor Poor Good Good Good 1000 
SAN Poor Poor Good Good Good 1000 
ASA Poor Poor Good Good Good - 
MABS Poor Poor Good Good Good 100 
SBC Poor Poor Good Good Good - 
TPU Poor Fair Good Good Good - 
TPC Poor Good Good Good Good - 
TPA Poor Poor Good Good Good - 
TPS Poor Poor Good Good Good - 
TPO Poor Fair Good Good Good - 
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Appendix 2.2 
Chemical resistance of some thermoplastics
[75][76][83][84]
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